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ABSTRACT
Human Immunodeficiency Virus (HIV-1) afflicts nearly 38 million individuals
worldwide (Joseph et al., 2013; “WHO | HIV/AIDS,” 2016). Despite the reduction in
disease mortality due to increased use of antiretroviral medication, HIV-1 associated
neurocognitive disorder (HAND) affects approximately 50% of HIV infected individuals
(Antinori et al., 2007; Castellon, Hinkin, Wood, & Yarema, 1998; Castelo, Sherman,
Courtney, Melrose, & Stern, 2006; Cysique & Brew, 2009; Heaton et al., 2011, 2015).
The brain itself is particularly sensitive to HIV-1 related viral proteins and viral infection
(Masliah, DeTeresa, Mallory, & Hansen, 2000), thus, it is vital to empirically examine
potentially effective therapeutics which may be capable of improving cognition in HIV-1
patients. In the contemporary literature, cognitive deficiencies encompassed by HAND
include deficits in: attention/information processing, language, abstraction-executive
function, complex perceptual motor skills, memory (short-term and working memory),
learning and recall, simple motor skills and sensory perceptual abilities, as defined by the
most recent HIV-1 nosology (Antinori et al., 2007).
Therapeutics capable of improving neurocognitive dysfunction in the HIV-1 brain
has yet to be established; therefore, the current study examined a potential therapeutic
theoretically capable of improving HAND related cognitive dysfunction: physical
activity. Physical activity has been shown to be the strongest environmental factor
capable of promoting the genesis of new neurons in the subgranular zone of the
hippocampal dentate gyrus (Fuss et al., 2014; Ji et al., 2014; Klein et al., 2016; M.-H. Lee
v

et al., 2013; Naylor et al., 2008; van Praag, Christie, Sejnowski, & Gage, 1999; van
Praag, Kempermann, & Gage, 1999; van Praag et al., 2002; van Praag, Shubert, Zhao, &
Gage, 2005; Vivar & van Praag, 2013). Furthermore, when examining the relationship
between physical activity and HIV-1 associated cognitive decline, there appears to be an
association between acute physical activity and cognitive function in human HIV-1+
patients (Dufour et al., 2013, 2018), evidence which suggests physical activity may be
capable of preserving/promoting cognitive function in the HIV-1 brain.
The current study determined whether promoting neurogenesis through physical
activity can act as a neuroprotective/neurorestorative therapeutic agent capable of
attenuating the progression of HIV-1 cognitive pathology. Upon completion of the
current study, the role of chronic HIV-1 viral protein expression on dentate gyrus
neurogenesis in the HIV-1 transgenic (Tg) rat brain was empirically established. The
current results provide evidence that HIV-1 viral proteins do inhibit neurogenesis (as
determined by doublecortin immunolableling), and that wheel running did not
significantly increase neurogenesis. However, wheel running significantly increased
dendritic spine length, volume and head diameter, as well as dendritic length. These
results suggest that physical activity may be an effective therapeutic for improving HIV1-dependent neurological synaptodendritic damage due to the expression of HIV-1 viral
proteins.
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CHAPTER 1
INTRODUCTION
In individuals infected with the HIV-1 virus, some patients (~50%) exhibit a
prominent deficiency in cognitive functioning (Antinori et al., 2007; Castellon et al.,
1998; Castelo et al., 2006; Cysique & Brew, 2009; Heaton et al., 2011, 2015; Stout et al.,
1995). Following the implementation of Highly Active Antiretroviral Therapies
(HAART) and subsequent Combined Antiretroviral Therapies (cARTs), the mortality
rates of HIV-1 patients was significantly reduced and delayed by a factor of several years
or even decades (Heaton et al., 2015; Joseph et al., 2013). Although the prevalence of the
most severe form of cognitive dysfunction, HIV-1 associated dementia (HAD) has been
reduced since the incorporation of cARTs, there has been a substantial increase in
prevalence of milder forms of neurocognitive dysfunction in the post-cART era, termed
HIV-1 associated neurocognitive disorders (HAND). Since the brain itself is particularly
sensitive to HIV-1 related viral proteins and viral infection (Masliah et al., 2000), it is
vital to determine effective therapeutics which are capable of improving cognition in
HIV-1 patients. In the contemporary literature, cognitive deficiencies encompassed by
HAND include deficits in: attention-information processing, language, abstractionexecutive function, complex perceptual motor skills, memory (short-term and working
memory), learning and recall, simple motor skills and sensory perceptual abilities, as
defined by the most recent HIV-1 nosology classifications (Antinori et al., 2007).
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Currently, there are no accepted interventions capable of improving neurocognitive
deficiencies in HIV-1+ patients.
The deficits in cognitive abilities are directly (damage directly attributed to the
virus) and indirectly (damage attributed to the consequence of immunosuppression and
neuroinflammation) due to HIV-1 infection of the central nervous system (CNS).
Specifically, HAND appears to be a product of dendritic and synaptic damage (Bertrand,
Aksenova, Mactutus, & Booze, 2013; Bertrand, Mactutus, Aksenova, Espensen-Sturges,
& Booze, 2014; Fitting et al., 2014; González et al., 2000; Hult, Chana, Masliah, &
Everall, 2008). The HIV virus primarily targets the lymphatic and nervous system
because both systems express the cluster of differentiation 4 (CD4) receptor, the primary
receptor of the virus. Additionally, co-receptors such as C-C chemokine receptor type 5
(CCR5) and C-X-C chemokine receptor type 4 (CXCR4) are also required by the HIV-1
virus to successfully attach to the T-lymphocyte and macrophages (respectively)
(Alkhatib, 2009). The viral envelope glycoprotein GP120 (gp120), allows cellular fusion
and entry of the virus into the targeted healthy cell (primarily monocyte-derived
macrophages (MDM) and microglia), and directly attaches to the surface receptor (CD4)
and the co-receptors (CCR5 & CXCR4). Importantly, the virus itself is unable to initially
cross the blood-brain barrier (BBB), however, the virus will cross the BBB by infecting
the MDM or infected monocytes, which are capable of crossing the BBB, a concept
called the "Trojan horse" hypothesis (Hult et al., 2008). Furthermore, the BBB can be
functionally and structurally disrupted by inflammation and accumulation of
inflammatory cytokines released as product of HIV-1 neural infection (specifically
increased tumor necrosis factor alpha (TNFα), interleukin 1 beta (IL-1β), and interleukin
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6 (IL-6) expression). Finally, the gp120 protein has also been shown to increase BBB
permeability and allow further monocyte transmigration of the BBB (Kanmogne et al.,
2007). Collectively, all of the aforementioned components appear to comprise the basis
of HAND on a molecular and neurological level.
In the human HIV-1 brain, there is evidence that the HIV-1 viral proteins
expressed by the HIV-1 virus directly affect the function of neurons comprising the CNS.
Although the HIV-1 virus does not directly infect neurons (González-Scarano & MartínGarcía, 2005; Nath, 2002), there is substantial evidence that HIV-1 transactivator of
transcription (Tat) and the HIV-1 surface protein gp120 have been shown to directly
affect neurons of the CNS in animal models of HIV-1 pathology. The expression of Tat
alone has been shown to promote neuronal apoptotic cell death, an effect that has been
shown both in vitro (Adams, Aksenova, Aksenov, Mactutus, & Booze, 2010, 2012;
Aksenova, Aksenov, Adams, Mactutus, & Booze, 2009; Bertrand et al., 2013, 2014) and
in vivo (Ferris, Frederick-Duus, Fadel, Mactutus, & Booze, 2009a, 2009b; Fitting, Booze,
Hasselrot, & Mactutus, 2008; Moran, Fitting, Booze, Webb, & Mactutus, 2014).
Furthermore, the HIV-1 envelope protein gp120 has been shown to solely affect the CNS
in in vivo (Bansal et al., 2000; Fitting et al., 2008; Fitting, Booze, & Mactutus, 2006;
Moran et al., 2014) and in vitro (Aksenov, Aksenova, Mactutus, & Booze, 2010; Turchan
et al., 2001; Wallace, Dodson, Nath, & Booze, 2006).
Important to the current dissertation, the HIV-1 protein Tat, has been shown to
reduce the number of adult-born granule cells (abGCs) in the subgranular zone of the
dentate gyrus (SGZ) of the dentate gyrus by acting as a Notch ligand, capable of
activating the Notch signaling pathway (Fan et al., 2016). Canonical Notch1 has also
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been shown to affect the proliferation of neurons of the SGZ (Breunig, Silbereis,
Vaccarino, Sestan, & Rakic, 2007; Lugert et al., 2010). Breunig et al., (2007) showed that
in the Notch1 and other Notch signaling components (hairy and enhancer of split-1
(Hes1), Recombining binding protein suppressor of hairless (Rbpsuh), delta-like protein
precursor 1 (Dll-1), and Jagged1 (Jag1)) were expressed in the SGZ of the hippocampus
at different ages of mice. Breunig and colleagues also showed that the Notch Intracellular
domains (NICD) are highly expressed in Type-III cells (as determined by Doublecortin
(DCX) positive immunolabeling, an accurate marker of immature neurons), which
suggests the Notch signaling pathway is important for the progression from immature to
mature neurons in the SGZ of the hippocampus in mice. The Notch1 KO animals had
significantly less complex arborization of the newly formed neurons, while the animals in
the NICD Tg group showed the greatest amount of dendritic complexity (significantly
more than controls or Notch1 knock-out (KO) animals). The results provided evidence
Notch signaling regulates the dendritic morphology in the newborn neurons of the SGZ
throughout maturation of the abGCs until they become functional granule cells. It is from
these results, one can surmise that Notch signaling is vital for A) promoting progenitor
proliferation, B) determination of cell fate (either neurons or glial cells), and C) neuronal
maturation and dendrite arborization (Breunig et al., 2007). Although Notch signaling
alone can alter the maturation and integration of abGCs, the mechanism of the potential
reduction in net neurogenesis in the HIV-1 brain is unknown. Therefore, in the current
dissertation it was hypothesized that the HIV-1 Tg sedentary animals would have fewer
DCX positive granule cells compared to the sedentary F344/N sedentary control animals
due to the presence of the HIV-1 transgene and the HIV-1 proteins expressed.

4

In addition to the effect of the viral protein Tat, gp120 has also been shown to
directly inhibit the creation of abGCs in Tg animal models of gp120 protein expression
(M.-H. Lee et al., 2013). The reduction in abGCs in the Tg animals was accompanied by
reductions in hippocampal brain-derived neurotrophic factor (BDNF) prior to wheel
running. Wheel running was capable of promoting abGC creation in the gp120 Tg
animals, yet this effect was transient and lost once wheel running was stopped. The
inhibited rate of abGC creation was remediated by physical activity in the Lee et al. 2013
study, and again, the effect was lost once running behaviors were halted. The results
provide seminal evidence that wheel running is capable of promoting abGC creation, and
furthermore, wheel running was associated with increased abGCs when actively
performing running behaviors in the HIV-1 protein animal models.
The reduction in abGC proliferation, maturation and integration in the HIV-1
brain has been proposed as a possible mechanism of HAND-associated neurocognitive
decline (Ferrell & Giunta, 2014; Venkatesan et al., 2007) and perhaps partially
responsible for HIV-1 pathogenesis (Okamoto et al., 2007). It has been suggested that the
relationship between HIV-1 viral proteins (specifically Tat and gp120) and
neurocognitive deficit progression may be a product of reduced neurogenesis in the HIV1 brain (Fan et al., 2016; Kaul, 2009; Krathwohl & Kaiser, 2004; Lawrence et al., 2004;
Okamoto et al., 2007; Schwartz et al., 2007; Venkatesan et al., 2007). As reported by M.H. Lee et al., 2013, physical activity may be capable of transiently restoring SGZ
neurogenesis following exposure to the HIV-1 viral protein gp120. For these reasons, it
was hypothesized that physical activity would improve working memory efficacy in the
HIV-1 Tg rat compared to sedentary animals in the spontaneous alternation Y maze.
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The HIV-1 Tg rat is one animal model for the study of HIV-1 disease progression
and neurocognitive alterations (Moran, Aksenov, Booze, Webb, & Mactutus, 2012;
Moran, Booze, Webb, & Mactutus, 2013). Of the nine genes encoded by the HIV-1 virus,
seven are chronically expressed in the HIV-1 Tg rat. The neurotoxic proteins found
within the CNS continue to be expressed in the HIV-1 Tg rat throughout the animal's
lifespan (Peng et al., 2010; Reid et al., 2001), similar to human HIV-1+ patients (Brew et
al., 2015) who adhere to cART, with low or non-detectable viral loads in serum. In the
HIV-1 Tg rat, 7/9 of the HIV-1 viral proteins are chronically expressed by the HIV-1
transgene throughout development and into adulthood and old age (Abbondanzo &
Chang, 2014; Peng et al., 2010). Therefore, the HIV-1 Tg rat provides a way to assess
HIV-1 neural alterations and behavioral manifestations through the chronic expression of
the HIV-1 associated viral proteins in the CNS. To examine HIV-1 disease, and
neurocognitive dysfunction, empirical research has predominantly utilized animal models
of HIV-1 to understand the neuropathological basis of HIV-1.
There has been a substantial amount of research published involving the HIV-1
Tg rat, including neuroinflammation processes (Royal et al., 2012; Royal, Wang, Jones,
Tran, & Bryant, 2007), sensorimotor gating (Moran, Booze, & Mactutus, 2013; Moran,
Booze, Webb, et al., 2013; Moran, Hord, Booze, Harrod, & Mactutus, 2016), contextual
fear memory retention (Nesil, Cao, Yang, Chang, & Li, 2015). Further research has also
examined attention and inhibition (Moran et al., 2014), temporal processing (McLaurin,
Booze, & Mactutus, 2017b; McLaurin, Moran, Li, Booze, & Mactutus, 2017),
development trajectory alterations (McLaurin, Booze, & Mactutus, 2016, 2017a) and
medium spiny neuron (MSN) dendritic spine alterations (Roscoe, Mactutus, & Booze,
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2014) in HIV-1 Tg rodent models. For a comprehensive review of HIV-1 disease
progression studies using the HIV-1 Tg rat, see (Fitting, Booze, & Mactutus, 2015;
Vigorito, Connaghan, & Chang, 2015). Thus far, physical activity has not been examined
as a potential therapeutic for HIV-1-dependent neurocognitive dysfunction.
Within the adult CNS, it has been shown new neurons can be created in the
“neurogenic niches”, such as the subgranular zone of the dentate gyrus (SGZ) of the
dentate gyrus. In the SGZ, new granule neurons (i.e. abGCs) are continually created by
NPCs to create adult-born granule cells. The abGCs then become integrated into the
established functional neurocircuitry which comprise the perforant and mossy-fiber
pathways of the hippocampus (Klein et al., 2016; M. C. Lee et al., 2013; Naylor et al.,
2008; van Praag, Christie, et al., 1999; van Praag, Kempermann, et al., 1999; van Praag et
al., 2002, 2005; Vivar & van Praag, 2013; Wu, Luna, & Hen, 2015).
The abGCs in their early stages of division and maturation are not yet integrated
into established circuitry nor fully-functioning units within the hippocampus (see
Aguilar-Arrendondo, Arias & Zepeda (2015) for review). For this reason, measuring the
abGCs in the earliest stages of their creation/integration provides little information about
their overall function in neuropsychological processes (Aguilar-Arredondo, Arias, &
Zepeda, 2015; Kempermann, Jessberger, Steiner, & Kronenberg, 2004; Seri, GarcíaVerdugo, Collado-Morente, McEwen, & Alvarez-Buylla, 2004; van Praag et al., 2002).
Additionally, nearly half of all abGCs are removed via apoptosis before becoming fully
mature and becoming integrated into the hippocampal network (van Praag, Christie, et
al., 1999). The rate of maturation and integration of the abGCs, although similar to the
rate of maturation/integration found during prenatal and early postnatal development
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(Stone et al., 2011), is variable. There is sufficient evidence that within four weeks after
creation, the abGCs become integrated into the existing hippocampal circuitry, and fully
mature around four months of age (van Praag et al., 2002), although other estimates have
established this time point of maturation and integration at five to six weeks after
creation (Stone et al., 2011). Importantly, the biomarkers of these abGCs are distinct, and
conventionally only expressed during specific stages of creation and maturation (AguilarArredondo et al., 2015; Kempermann et al., 2004; Seri et al., 2004). As the goal of the
current project was to quantify the integration of these abGCs and not necessarily the
creation of the abGCs, the intermediate biological marker DCX was used to examine
these intermediate, immature neurons. Doublecortin is expressed in the type 2b cells (D1
according to the definitions of Seri et al., 2004) which are in the transitional stage to
becoming granule cells (Aguilar-Arredondo et al., 2015; Kempermann et al., 2004; Seri
et al., 2004). Doublecortin is a well-known biomarker of microtubule construction, used
in the formation and migration of neurons during neurogenesis (Francis et al., 1999;
Gleeson, Lin, Flanagan, & Walsh, 1999). Importantly, DCX is not expressed in the
mature granule cells (Calbindin positive), nor in the early progeny (Type 1 and 2a cells,
which are nestin-positive), and is only expressed during the maturation and migration
stages (Type 2b, Type 3, and immature neuron stages) (Aguilar-Arredondo et al., 2015;
Kempermann et al., 2004; Seri et al., 2004). The more mature granule cell axons
comprise the mossy fiber pathway from the granule cell layer of the dentate gyrus to their
termination sites on the dendrites of the pyramidal cells of the Cornu Ammonis (CA) 3
subfield of the hippocampus (Aimone, Deng, & Gage, 2011; McHugh et al., 2007;
Treves, Tashiro, Witter, & Moser, 2008). There, the axonal projections of the dentate
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gyrus granule cells are capable of influencing the firing of the CA3 pyramidal cells
(Henze, Wittner, & Buzsáki, 2002).
Physical activity and exercise has been shown to be a reliable environmental
factor capable of promoting SGZ neurogenesis (Fuss et al., 2014; Ji et al., 2014; Klein et
al., 2016; M. C. Lee et al., 2013; Naylor et al., 2008; Stone et al., 2011; van Praag,
Christie, et al., 1999; van Praag, Kempermann, et al., 1999; van Praag et al., 2002, 2005).
Exercise significantly increases the volume of the hippocampal structure in animals
(Biedermann et al., 2016; Fuss et al., 2014) and in humans (Beadle et al., 2015; Erickson
et al., 2009, 2011), potentially through increased neurogenesis. Furthermore, when
examining the relationship between physical activity and HIV-1 associated cognitive
decline, there appears to be an association between acute physical activity (within the
previous 72 hours (h)) and improved cognitive function in human HIV-1+ patients
(Dufour et al., 2013). The improved cognition following exercise in the HIV+ brain
appears to continue to preserve cognitive functionality during follow-up exams in these
exercising HIV-1+ individuals (Dufour et al., 2018), with significant differences in
consistent physical activity participants compared to no physical activity and inconsistent
physical activity groups. Finally, the results reported by the Dufour et al. group have been
replicated in a separate, older population of HIV-1+ patients (Fazeli et al., 2015), with
physically active participants showing reduced neurocognitive decline and improved
executive function compared to physically inactive participants. It was hypothesized that
physical activity would improve working memory in the HIV-1 Tg animals running
animals compared to sedentary controls.
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Physical activity has been shown to promote neurogenesis, increase hippocampal
volume (Beadle et al., 2015; Erickson et al., 2009, 2011), and improve memory function
in humans (Erickson et al., 2011; Pontifex, Hillman, Fernhall, Thompson, & Valentini,
2009) and in animals (Biedermann et al., 2016; Fuss et al., 2014). As to whether these
benefits of exercise-induced neurogenesis can occur in the HIV-1 Tg rat has yet to be
determined. Previously, we have shown ovariectomizd HIV-1 Tg female animals have a
reduction in running distances and in the number of running bouts during sessions
(Cranston, 2016), which by itself may reduce the ability for proliferation of the newborn
neurons compared to control running animals. For this reason, in the current study,
animals were allowed a significant amount of time to attain stabilized levels of physical
activity in the voluntary running wheel. Since physical activity such as wheel running
promotes SGZ neurogenesis (M. C. Lee et al., 2013; Naylor et al., 2008; van Praag,
Christie, et al., 1999; van Praag, Kempermann, et al., 1999; van Praag et al., 2002, 2005),
the goal of the current project was to utilize physical activity to promote dentate gyrus
neurogenesis in the HIV-1 Tg rat, and potentially improve neurocognitive processes, such
as working memory. It was hypothesized that the intact female and male animals would
be willing to run in the voluntary running wheel and promote neurogenesis in the SGZ.
Furthermore, within individual running wheel sessions, there was variation on the
continuous variable of wheel revolutions, as well as the number of running bouts per
session and the mean length of these running bouts. This individual variation was used to
establish a dose-response association between running wheel activity and the bouts which
comprise the overall wheel running and neurogenesis in the wheel running animals.
Correlational analysis assessed the association between wheel running behaviors and
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SGZ neurogenesis. Specifically, correlations between total wheel revolutions, running
bout frequency and mean running bout length were correlated with DCX positive
(DCX+) cell numbers. Individual running behaviors were measured on a continuous
variable, a dose-dependent association was correlated between wheel running parameters
and DCX+ cell numbers.
Wheel running variation is also well established to be affected by female steroid
gonadal hormones (Fahrbach, Meisel, & Pfaff, 1985; Gerall, Napoli, & Cooper, 1973;
Kent, Hurd, & Satinoff, 1991; G. H. Wang, 1923) such as the estrogens and the
progestins. The estrogens and progestins are released due to hypothalamic signaling
(specifically gonadotropin releasing hormone (GnRH)) which causes subsequent release
of follicle stimulating hormone (FSH) which affects the ovaries, and causes the release of
estrogens and progesterone. For this reason, all female animals were estrous stage tracked
through daily vaginal lavages, and cell cytology (Centola, 1978) was determined to
control for the effects of ovarian hormones on wheel running. It was hypothesized that
wheel running distances in the female animals would be increased during the estrus phase
of the estrous cycle. Additionally, all female animals were behaviorally tested in the Y
maze during the diestrus phase of their estrous cycle, and euthanized during the diestrus
phase to controls for histological variation due to estrous cycle phase.
It was hypothesized that sedentary HIV-1 Tg animals would show a reduction in
the number of DCX+ neurons in the SGZ of the hippocampus based on previous
literature (M.-H. Lee et al., 2011). It also was hypothesized that physical activity would
promote increased neurogenesis in the SGZ of the hippocampus in the HIV-1 Tg running
animals compared to sedentary HIV-1 Tg animals. It was hypothesized that the number
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of DCX+ neurons in the HIV-1 Tg running animals would be increased in number and
dendritic complexity, compared to the HIV-1 Tg sedentary animals, and similar in the
number of DCX+ granule cells compared to the F344/N sedentary control animals.

It was therefore the guiding hypothesis of the current project that physical activity
would promote SGZ neurogenesis, producing more abGCs in the SGZ of the dentate
gyrus and improve HAND-related cognitive deficits in the HIV-1 Tg rat. To assess the
capacity of physical activity to promote neurogenesis, the current dissertation addressed
the capacity of SGZ neurogenesis in the HIV-1 Tg rat. These hypotheses were examined
by:
A) determining if environmental factors, such as physical activity (i.e. wheel running),
promoted SGZ neurogenesis in the HIV-Tg rat
B) determine if maturing granule cell dendritic complexity and spine development was
improved in the HIV-1 Tg rat following physical activity compared to sedentary controls
C) examining dendritic spines of mature dentate gyrus granule cells for synaptodendritic
alterations as a product of HIV-1 and determining whether physical activity improved
synaptic integrity.
Spontaneous alternation in the T, Y, or plus maze has been established as a
sensitive measure for assessment of hippocampal damage/dysfunction in rodents (Deacon
& Rawlins, 2006; Ellen & Deloache, 1968; C. T. Johnson, Olton, Gage, & Jenko, 1977;
Kirkby, Stein, & Kimble, 1967; Lalonde, 2002; Means, David Leander, & Isaacson,
1971; Roberts, Dember, & Brodwick, 1962). The spontaneous alternation Y maze is a
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convenient and effective assessment of working memory in rodents. Animals with
hippocampal damage and lesions do not alternate their path within the Y/T maze as often
as non-lesioned controls (reduced alternation), but rather, are more likely to return to
previously explored arms (working memory error) of the maze compared to non-lesioned
controls. The motivation for traversing the novel arm is entirely intrinsic and depends
upon the innate desire to explore/examine novel environments in search of potential
rewards, such as food or mates. In the current study, it was hypothesized that the HIV-1
Tg running animals would perform better than HIV-1 Tg sedentary animals.
Importantly, dentate gyrus SGZ neurogenesis can be promoted through behavioral
interventions, primarily through physical activity in mammals (Klein et al., 2016;Ko et
al., 2009;Lee et al., 2013;Lee et al., 2011;Stone et al., 2011;Van Praag H. et al., 1999;Van
Praag et al., 1999;Van Praag et al., 2005). Furthermore, the increased hippocampal
neurogenesis following physical activity has been shown to improve cognitive function in
animals (Sahay et al., 2011; Stone et al., 2011; van Praag, Christie, et al., 1999; van
Praag, Kempermann, et al., 1999; van Praag et al., 2005; Wu et al., 2015). Newborn
neurons created during adult SGZ neurogenesis are integrated into the existing
hippocampal circuitry; and as they mature, become vital, functional components of the
hippocampal circuit (Adlaf et al., 2017; Aguilar-Arredondo et al., 2015; Danielson et al.,
2016; McHugh et al., 2007; Nakashiba et al., 2012; Ramsaran & Frankland, 2016; Sahay
et al., 2011; Saxe et al., 2006; Stone et al., 2011; van Praag et al., 2002; Vivar et al.,
2012; Vivar & van Praag, 2013). The hippocampus and the circuits it is comprised of is
an integral neuroanatomical structure, which is essential for effective working memory in
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animal models of hippocampal injury/lesions (C. T. Johnson et al., 1977; Olton &
Feustle, 1981; Olton, Walker, & Gage, 1978; Olton, Walker, & Wolf, 1982).
Alterations in working memory in the HIV-1 Tg rat following physical activity
are unknown. Previously, two separate empirical studies utilized the spontaneous
alternation task in the HIV-1 Tg rat to assess the working memory function in these
transgenic animals (without physical activity). Both studies showed that the HIV-1 Tg
animals exhibit deficits in working memory function in the T/Y maze spontaneous
alternation task (Nesil et al., 2015; Repunte-Canonigo et al., 2014). The study by Nesil et
al., 2015 reported preservation of working memory following chronic administration of
nicotine in the HIV-1 Tg animals compared to HIV-1 Tg saline-injected controls. The
current project hypothesized that physical activity was capable of improving working
memory in the exercised HIV-1 Tg rat, compared to sedentary HIV-1 Tg animals.
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CHAPTER 2
METHODS
2.1 SUBJECTS:
40 HIV-1 Tg animals (20 male, 20 female, age-matched, Hsd: HIV-1(F344/N);
Harlan, Indianapolis, IN) arrived at the AAALAC-accredited facility at ~60 days of age.
This age was selected to ensure the entire study could be completed before the animals
reach 300 days of age when running activity reaches its maximal level (Slonaker, 1912).
40 F344/NHsd (20 male, 20 female, age-matched to HIV-1 Tg group) acted as genotypic
control subjects. Animals were assigned numbers through random assignment, and
pair/group housed with similar animals (matched for sex & genotype). All animals were
pair- or group-housed throughout the duration of the study. Animals were provided ad
libitum access to food (Pro-Lab Rat, Mouse, Hamster Chow #3000) and water for the
entirety of the study.
Guidelines established by the National Institutes of Health (NIH) were used to
house animals in AALAC-accredited facilities. The targeted environmental conditions for
the animal facilities was 21° ± 2°C, 50% ± 10% relative humidity and 12h light and 12h
dark cycle with lights on at 0700h (EST). The University of South Carolina Institutional
Animal Care and Use Committee (IACUC) approved the project under federal assurance
(#D16-00028). All animal procedures were performed in accordance with this federal
assurance.
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The animals arrived at the facility in 5 separate cohorts. The first cohort was 22
female animals, with one animal requiring replacement once the 2nd cohort arrived, the
second cohort was 9 female animals. 20 of the first animals to arrive comprised the 1st
running group. The final cohort of females arrived 18 days later and was added to the 2nd
cohort to create the 2nd running group. The first group of male animals (n=20) arrived one
month after the final group of female animals arrived and comprised the 3rd running
group. The final cohort of male animals arrived 7 days after the first cohort of males and
comprised the 4th running group. The male animals were much younger than their female
counterparts and were allowed to grow and mature before being allowed to run.
2.2 WEIGHT AND ESTROUS CYCLE TRACKING
Each day at 16:00 all female animals were vaginally lavaged to determine estrous
cycle stage (G. H. Wang, 1923). Estrous cycle stage was classified as estrus, metaestrus,
proestrus, or diestrus based on visual cell cytological examination by the experimenter.
The same experimenter assessed every vaginal smear to determine cell stage for
measurement reliability. Estrous cycle tracking was determined daily, from the first day
of the female animal’s arrival at the facility until the animal was euthanized.
Each week female animals were weighed on a digital scale (Mettler Toledo,
Columbus, OH) and weights recorded in grams, to the 0.1 of a gram, followed by
weighing of all male animals. All body weights and estrous cycle information were
recorded in the laboratory notebook, and electronic databases were established in
Microsoft Excel (2007) (Microsoft Corporation, Redmond, WA) for data storage and all
data stored on a secured data cloud (Dropbox Inc., San Francisco, CA).
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Female animals were vaginally lavaged (Centola, 1978) each afternoon (~16:00h)
to record estrous cycle stage prior to access to the running wheel. It is well documented
that female animal's running behaviors are affected by estrus cycling (Fahrbach et al.,
1985; Gerall et al., 1973; Kent et al., 1991; G. H. Wang, 1923). Running wheel activity
for the two sexes was analyzed independently, as female animals tend to run significantly
greater distances than males (Shirley, 1929). Animal running groups began wheel
running at 19:00 and continuing until all animals completed their daily running.
2.3 WHEEL RUNNING:
2.3.1 Wheel Running Apparatus
The running wheel apparatus was a polypropylene rectangular chamber (45.5
centimeters (cm) long, 24cm wide and 20.5cm deep) with a 34cm diameter running
wheel attached to the chamber lid at the midpoint. Magnetic sensors on the lid and wheel
recorded revolutions by the recording software. All data was recorded by Vital View 4.0
(Mini Mitter Inc., Bend, OR) software which records wheel revolutions. The data was
collected into 1-minute cumulative bins for wheel revolutions. Disabled running wheels
were created with these apparatuses by locking the running wheel with clips at two points
to prevent any rotation of the running wheel in either direction. Sedentary controls from
both genotypic groups were placed in the disabled running wheels at the same time and
with the same procedure as running animals. Animals ran daily until each animal reached
stabilized nightly running distances (non-significant differences between sessions in
running distances). The room in which the animals ran was nearly completely dark (0.10.2 lux).
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2.3.2 Animal Arrival and Wheel Assignment Procedure:
Animals arrived at the research facility, and handled for 7 days by the
experimenter. Following handling, animals were pseudo-randomly assigned to their
running wheels (balanced block randomized) prior to beginning any wheel running
sessions. The animals were balanced between running condition and genotype so that
each animal had an equal chance to be selected into the running or sedentary conditions
(locked wheel). The animals were balanced based on location (top or bottom row) and
equal numbers of F344/N controls and HIV-1 Tg animals in each session and balanced
across running condition and wheel location. The animals were habituated to the running
wheels for the first seven days following handling.
Since the female animals arrived at the facility first, they were the first group to
start the wheel running stage of the current study. From the first cohort of 22 female
animals, 20 were block-randomized into the running wheels. The block randomization
was done to ensure that each genotypic group (F344/N controls and HIV-1 Tg) animals
were equally likely to be selected and equally balanced between location in the running
wheel room (top or bottom rows) and running condition (running and sedentary). This
procedure was repeated for each subsequent cohort of animals as they arrived at the
facility. Once 8 more female animals arrived at the facility (cohort 2), a second running
group was created, and randomized in the same fashion as the first running group. The
2nd running group was started at ~20:10, after the 1st running group completed their
session and were returned to the colony room (See Figure 2.2). All wheel running
apparatuses were cleaned during the animal transfer with ~10% Ethyl alcohol (EtOH) to
remove urine, feces, and olfactory cues. When the final 10 females (cohort 3) arrived at
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the facility they were added to the 2nd running group, which completed the balance of
genotype and running condition in the 2nd running group.
The male animals arrived at the facility several weeks after the female animals in
two cohorts of 20 animals (evenly balanced, with 10 F344/N control animals and 10
HIV-1 Tg animals in each cohort). The first cohort (cohort 4) and were younger than their
female counterparts and were allowed to grow for 6 weeks before allowed access to the
running wheels. Once the males reached a body weight slightly above the female animals
when they began wheel running, the males were allowed access to the running wheels.
Cohort 4 comprised the newly created 3rd running group and were evenly balanced in the
same fashion as the female animals (See Figure 2.2).
Once the 3rd running group (males, cohort 4) was established, the female animals
which had been running for a minimum of 42 consecutive days were moved to a later
running time, with the 3rd running group of males beginning their wheel running at 19:00,
the 2nd running group stayed at their ~20:00 time slot, and the 1st running group starting
at ~21:00 (See Figure 2.2 for details). This procedure was done to ensure that any effect
of time-of-day on wheel running behaviors was controlled for (Goff & Finger, 1966; M.
T. Peng, Jiang, & Hsü, 1980; Shirley, 1929), and that each sex experienced similar
environments during wheel running. The final group of male animals (cohort 5) were
allowed to grow to the same age as the cohort 4 males before beginning their wheel
running, and where randomized and assigned their running wheel and running condition
in the same fashion as all other animals and comprised running group 4. This running
group was integrated into the established running group, and began wheel running at
~20:00. This start time was selected as it was identical to the 2nd running group when
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they began wheel running measures. This assignment was maintained for 6 weeks (42
days) (See Figure 2.2).
After the 42nd day of wheel running by the cohort 5 males (running group 4), the
animals in each running group was switched again, with the females returning to their
initial running times, and the males replacing the female animals in their later running
slots. This procedure ensured that each sex had equal experience with the running wheels
and were devoid of time-of-day-dependent alterations in their wheel running behaviors
(Goff & Finger, 1966; M. T. Peng et al., 1980; Shirley, 1929) (See Figure 2.2 below)
As animals were euthanized per protocol (see section 2.6 for details), the wheel
running groups and running times were adjusted to be more efficient. Importantly, the
animals always stayed in their assigned running wheel and were maintained in their sex
cohorts, with males and females only running with animals of the same sex. Running
groups 1 & 2 (females) were the first group to be collapsed into a single running group
which began running at ~19:00. The male animals (running groups 3 & 4) were
combined and began running at the 20:00 running slot (see Figure 2.2).
2.4 WHEEL RUNNING PROTOCOL AND DATA COLLECTION
Nocturnal running behaviors were recorded following the 7 days of handling. As
rats are a nocturnal animal, wheel running measures were completed during the active,
nocturnal hours to produce the most accurate assessment of animal running behaviors.
Animals were first habituated to the wheel running apparatus for seven days before
running behaviors were recorded for the study (Habituation data was recorded, see
results). The running sessions were ~66 minutes in length to ensure every animal could
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run for at least 60 minutes (animal loading took six minutes or less, loading times were
recorded in the laboratory notebook). The running wheel data was selected to be sampled
every one minute, and session total running distances were summed to determine overall
running distances for each session for the running animals. Sedentary animals were also
placed into disabled running wheels which were not able to be rotated at the same time
and in the same environment as the running animals. To reduce the olfactory influence of
previous animals, each evening following the running session(s), each apparatus was
cleaned with 10% EtOH to remove urine, feces, and olfactory cues from the apparatus.
All animals were run daily until sacrifice, as cessation of running returns the rates of
neurogenesis to non-running levels or lower (M. C. Lee et al., 2013; Nishijima,
Kamidozono, Ishiizumi, Amemiya, & Kita, 2017).
Wheel running, like all other animal behaviors, occur in distinct “bouts” of
engagement (i.e.-wheel revolutions) and disengagement (i.e.zero wheel revolutions)
termed “Interbout Intervals” (IBI) (Eikelboom & Mills, 1988; Newland, 1995; Shull,
2011). Through an examination of the bouts and IBI’s (microstructural behavior
analysis), empirical research can determine potential motivational and motoric deficits
found in wheel running (Brackney, Cheung, Neisewander, & Sanabria, 2011; Hoffman &
Newland, 2016; J. E. Johnson, Pesek, & Newland, 2009). Microstructural analysis of
wheel running has been used to assess both motor function and motivational aspects of
running behaviors (Hoffman & Newland, 2016; J. E. Johnson et al., 2009). Specifically,
reductions in the rate of responding (i.e.wheel revolutions/minute) are suggestive of
altered motor function, and conversely, alterations in the number of running bouts are
suggestive of alterations in motivation (Hoffman & Newland, 2016; J. E. Johnson et al.,
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2009). Thus, detailed behavioral analysis of wheel running was used to assess
motivational differences in the HIV-1 Tg rat to determine whether the animals have a
reduction in motivation for natural rewarding behaviors. In the current study, wheel
running sessions were examined, and bout (defined as consecutive 1-minute bins of
activity with at least 1 wheel revolution recorded) and IBI (consecutive 1-minute bins of
no activity with no wheel revolutions recorded) were extracted. The data were pooled to
determine the number of bout and IBIs during each session, and the average length (in
consecutive minutes) that these behaviors occurred. Since there was a pronounced effect
of animal sex in wheel running behaviors, the sexes were analyzed separately (See Figure
2.1).
2.4.1 Wheel Running, Latency to initiate behaviors
Latency to initiate the first wheel revolution was determine by examining the
individual data of the animals and was quantified as the number of minutes from the start
of the session until the first wheel revolution.
2.4.2 Wheel Running, Maximal Running Speed
Individual peak running speeds were determined by the following equation: 95th
percentile of any one-minute bin * wheel circumference (1.06meters) for each animal in
the running condition (Mahoney et al., 2013; Ottenweller et al., 1998). The 95th percentile
was used to make sure that spurious minute bins were excluded in the comparison. These
data were analyzed for genotypic differences between the two sexes for the first 42 days
of wheel running.
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2.4.3 Stabilization of Wheel Running Behaviors Criterion:
The coefficient of variance was used to determine "stabilized" running behaviors
with each animal's weekly means. To reach criterion for stabilized running distances, the
previous three weeks of individual weekly means was analyzed in SPSS (v.24) to
establish a coefficient of variation (CV) in the mean weekly running distances of the
animals. The coefficient of variation was established by the following equation:

fifteen percent CV for three consecutive weekly mean running distances in each animal
was the established criterion for an animal to be deemed "stabilized", and progress
forward in the study to behavioral testing procedures. Fifteen percent was chosen as the
criteria for stabilization based on previous studies of wheel running behaviors (Billat,
Mouisel, Roblot, & Melki, 2005; Gurney, Fleck, Himes, & Hall, 1998; Russell, Epling,
Pierce, Amy, & Boer, 1987), where within-subject CV's ranged from >10% to ~25%.
Additionally, in a prior study within our lab (Cranston, 2016), we showed the stabilized
nocturnal running distances in our animals over three weeks had a mean CV of 12.9%,
with a range from 2%-52% in well-trained animals.
2.5 Y MAZE:
2.5.1 Apparatus
The Y maze apparatus was comprised of Perspex® acrylic opaque material which
formed the walls of the Y maze, which were 10 inches tall, and 1/2 inches thick. The goal
arms and starting arm were 3 5/16 inches wide and the starting area at the base of the Y is
5 3/4 inches in length. The starting area at the base of the Y contained slots to place a
23

removable opaque Perspex® acrylic guillotine door, which was removed to start the
Alternation Trial procedure. The arm from the start area to the branch of the Y where the
arm selection was made (i.e.-goal arms) were 19 5/16 inches from the point of the
guillotine door in length and 3 5/16 inches wide. Each arm of the apparatus was 3 5/16
inches wide and measured 19 5/16 inches from the point of the guillotine door to the end
of the goal arm in length. A mirror hung the Y Maze stand which allowed the
experimenter to view the Y maze without being seen by the animals within the maze. The
apparatus itself did not contain any markings and was uniform in color, composition, and
construction. There were no visual, olfactory, tactile, or auditory cues contained within
the apparatus.
2.5.2 Pairing and Protocol
Once the animals reached stabilized running distances, the animals were provided
access to a maze in the shape of a “Y” to asses working memory. The procedure utilized
was the “Spontaneous Alternation” protocol developed by Deacon and Rawlins, and
slightly adapted so that the animals were never touched by the experimenter, even if they
did not move within the Y maze (Deacon & Rawlins, 2006).
In the male animals, running animals and sedentary animals were randomly paired
with another male animal from the same running group and matched for genotype. In the
female animals, the pairing of the sedentary animal was based on the estrous cycle stage
the running female animal (both animals were required to be in the diestrus stage). Once
the pairings were established, the paired animals were always tested with their
established partner. Three Y-maze trials were performed for each animal, and at least 7
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days separated the Y-maze trials to maintain novelty to the Y-maze apparatus and
promote maze exploration.
In the paired females during the 2nd and 3rd Y-maze trials, if one of the animals in
a pair was not in diestrus during subsequent trials (2nd and 3rd trials) the animals waited
until their next synchronization of estrus stage. If the partner was within 24h of diestrus,
they performed their trial on the next evening. All female animals were run through the
Y-maze within 24h of their established partner.
2.5.3 Task Procedure:
Prior to testing, the testing room contained a speaker which produced 70db
of constant white noise. The room was illuminated by a low-light source (2.8-2.9 lux) for
viewing of the animals in the Y maze. Prior to testing, animals were placed in the testing
room for 10 minutes to become habituated to the testing room prior to the starting of the
procedure.
First Trial, “sample trial”: Following the habituation to the testing room, the
animals were placed in the Y-maze apparatus in the starting area with all guillotine doors
raised. Two stopwatches were started; one to measure the animal's latency to leave the
goal box (criterion was that all 4 paws and the tip of the animal's tail crossed the line of
the guillotine door slots of the starting area), and the second to measure the time it took
for the animal to make a goal arm choice. Once the animal has placed all 4 paws and the
tip of their tail into one of the goal arms of the Y (criterion was the animal fully crossing
the slots where the arm guillotine doors are placed with all four paws and the tip of their
tail). Once a selection was made, the animal was confined to the selected arm for 30
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seconds by the placement of the guillotine door to the selected goal arm. At the end of 30
seconds, the animal was removed from the goal arm, and transferred to a separate
intertrial interval (ITI) box for 60 seconds. During the ITI, the Y maze was wiped down
with 10% EtOH to remove urine and feces, and all guillotine doors were removed from
the goal arms, and a guillotine door was placed in the starting area, blocking the starting
area from the rest of the apparatus. The chosen arm during the sample phase was
recorded.
Alternation Trial: Following the 60-second ITI, the animal was placed in the
starting area once again, facing away from the guillotine door confining it in the starting
area. The guillotine door was quickly and silently removed, and the two stopwatches
were started (one to measure the animal's latency to leave the goal box, and the other to
measure the animal’s latency to select a goal arm. Criterion during the alternation phase
was identical to that of the sample phase criterion. Once the animal had crossed the line
of the guillotine doors to either goal arm with all 4 paws and the tip of their tail, the
second timer was stopped, the time recorded on the Y maze sheets. The animal was then
removed from the goal arm and returned to the home cage. This procedure (sample trial
& alternation trial) was repeated three times, with each trial at least 7 days after the
previous trial for each animal. The procedure produced the dependent measures of the
latency to leave the start box and the time to make a choice. The arm selected during the
alternation trial was recorded. The alternation trial was limited to two minutes (120
seconds) in length. If the animal did not traverse a goal arm after 120 seconds (to
criterion of all 4 paws and full tail within the arm), the animal was removed from the
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apparatus and a zero was recorded for the latency to make a choice and for the
correct/error ratio.
If the animal returned to the previously traversed arm (the one selected during the
sample phase), it was considered an error on the part of the animal (working memory
error). If the animal traverses the unvisited arm during the alternation phase, it was
considered a correct selection on the part of the animal (successful working memory).
The number of errors by the animal (traversing a previously traversed arm) was the
numerator in the ratio created, with the denominator being the number of trials in total
(3). Number of correct/3= X *100 created a “percentage correct” measure for each
animal.
A 2-minute (120 seconds) cutoff was used to stop the trial. If the animal did not
make a successful choice at the end of the 2 minutes during either phase, the trial was
ended and the data from that trial was excluded from the analysis (Deacon & Rawlins,
2006).
The number of failed trials in each group was recorded, and these data were
analyzed with Chi-Square analysis of independence for each sex independently.
2.6 EUTHANASIA AND TISSUE SECTIONING PROCEDURE:
Animals were removed directly from the running wheel chamber, deeply
anesthetized with SevoThesia™ sevoflurane (Henry Schein Animal Health, Dublin, OH)
and transcardially perfused with 0.1M Phosphate-buffered saline (PBS) ~100-200ml,
followed directly by chilled 4% paraformaldehyde (PFA), ~100ml (Sigma-Aldrich, St.
Louis, MO) made within the previous 48h. Whole brains were extracted and placed in
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PFA for 10 minutes, then immediately sectioned using the Rat Brain Matrix (Ted Pella,
Inc., Redding, CA)
Brain tissues were sectioned with the rat brain matrix in coronal sections of
500µm thickness, starting at approximately Bregma -1.9 (Kjonigsen, Leergaard, Witter,
& Bjaalie, 2011; Paxinos & Watson, 2014). This procedure produced between 8 and 12
coronal sections through the hippocampus structure. Brain sections were collected into
labeled, 24-well polystyrene plates (Corning Inc., Corning, NY), four to six 500µm
thickness slices were selected for DCX Immunohistochemical processing (odd slices 111) and the alternating slices were processed with DiOlistic labeling optimized to label
granules cells of the dentate gyrus. Tissue wells were filled with ~1ml of 0.1M PBS, then
immediately processed.
2.7 DIOLISTIC LABELING OF GRANULE CELLS
2.7.1 Preparation of Tefzel Tubing
Approximately seventy cm of new Tefzel tubing (IDEX Health Sciences, Oak Harbor,
WA) was cut. Polyvinylpyrrolidone (PVP) (100 mg, EMD Millipore Corp., Billerica,
MA) was dissolved into 10ml of double distilled H2O (ddH2O), vortexed, and drawn into
the Tefzel tubing and allowed to sit for a minimum of 10 minutes.
2.7.2 Preparing the DiOlistic cartridges
Tungsten beads (100mg, Bio-Rad, Hercules, CA) were dissolved in 200µl of 99.5%
methylene chloride (Sigma-Aldrich, St. Louis, MO). Crystallized DiI (4mg, Invitrogen,
Carlsbad, CA) was dissolved in 300µl methylene chloride. All of the bead solution was
applied to a glass slide and allowed to air dry completely. The DiI solution was added to
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the affixed tungsten beads on the glass slide and mixed slowly with the pipette tip until
completely dried. A razor blade was used to scrape the dye/bead mixture into two (2)
1.5ml Eppendorf™ (Eppendorf North America, Hauppauge, NY) tubes with 1.5 ml of
ddH2O water. These two tubes were probe sonicated with a Branson Sonifier 150
(Branson Ultrasonics; Danbury, CT) for a minimum of 10 minutes to ensure complete
breakup of the beads which had adhered together by the DiI solution. The two tubes were
then combined into a 15ml (BD Falcon, San Jose, California) and sonicated. The
previously prepared PVP/water mixture was removed from the Tefzel tube and the
DiOlistic mixture was drawn into the tube between periodic vortexes to maintain
homogenization. The filled tubing was placed in the tubing prep station (Bio-Rad,
Hercules, CA) and rotated for 5 minutes to distribute the coated tungsten beads evenly in
the Tefzel tubing. The rotation was stopped momentarily while the remaining water was
slowly drawn from the tubing, and rotation resumed for another 30 minutes. Nitrogen gas
was added to ensure drying for another 30 minutes at a flow rate of 0.4 L/m. Once dry,
the tubing was cut into 13mm segments and stored in the dark.
2.7.3 DiOlistic Labeling using the Helios Gene Gun
PBS was removed from the wells, and alternate slices (even slices 2-12) were
DiOlistically labeled with the Helios® Gene Gun (Bio-Rad, Hercules, CA) following
previous reported procedures (Roscoe et al., 2014; Seabold, Daunais, Rau, Grant, &
Alvarez, 2010) with adaptations made to optimize labeling of the granule cells of the
dentate gyrus. Prepared cartridges of the gene gun ballistically delivered tungsten beads
to the tissues at 70psi through a double 3μm pore filter papers with the tissue ~2.5cm
away from the gun barrel. The labeled slices were rinsed 3x with PBS and placed into the
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4°C refrigerator and allowed to incubate for 2 hours to allow dye diffusion before
mounting. After the 2h incubation, each slice was mounted on 25 x 75 x 1mm Superfrost
Plus slides (VWR, Radnor, PA), completely covered by ProLong™ Gold antifade reagent
(Invitrogen, Carlsbad, CA), coverslipped with 22 x 50 x 1.5mm VWR micro cover glass
(VWR, Radnor, PA), and allowed to cure overnight in a dark location before imaging.
2.8 IMMUNOHISTOCHEMISTRY (IHC):
Alternating 500µm thick tissue sections were washed in PBS then incubated for
15 minutes at room temperature with 0.3% H2O2 (Thermo Fisher Scientific, Waltham,
MA) concentration in a 1:1 solution of 0.1M PBS and ≥ 99.7% methanol (Thermo Fisher
Scientific, Waltham, MA) to enhance dendritic staining. After incubation, tissues were
washed 3x with PBS and all bubbles were removed from the tissue and wells. Tissues
were placed for 2 hours in blocking solution (4% horse serum in 0.1M PBS + 0.5%
Triton X-100) at room temperature. Blocking solution was removed, and tissues were
washed 3x for 5 minutes with 0.1M PBS.
Primary antibody Doublecortin (DCX)(Santa Cruz, #sc-271390), mouse
monoclonal, kappa light chain) was diluted into PBS + 0.5% Triton X-100 + 1% Horse
Serum (Stock Solution) at a 1:50 concentration; and incubated overnight at 4°C with
constant motion. The next day (following a minimum 12h of incubation), the primary
antibody solution was removed from the wells, and the tissues rinsed with PBS 3x.
Biotinylated Horse Anti-Mouse IgG antibody, rat adsorbed (Vector Labs, # BA-2001,
Burlingame, CA) was added to tissue wells at a 1:200 concentration and allowed to
incubate for 2 hours at room temperature. Following the 2h incubation, the secondary
antibody was removed from the wells, and tissues were rinsed 3x with PBS. Tissues were
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mounted on 25 x 75 x 1mm Superfrost Plus slides (VWR, Radnor, PA) and allowed to
attach to the slide for ten (10) minutes before further processing. Tissues were then
completely covered with avidin-biotin-peroxidase complex (ABC Elite Kit, Vector Labs,
Burlingame, CA) for 30 minutes. These tissues were then washed with PBS for 5
minutes. Once the tissues were washed, 3, 3'diaminobenzidine (DAB, peroxidase
substrate kit, Vector Labs, Burlingame, CA) was applied to the tissues for 15-60 seconds
(until preferred intensity was achieved). The tissues were then dehydrated through graded
alcohol steps. First, slides were completely submerged in 70% EtOH for 2 minutes, then
tapped dry and moved to 95% EtOH for 3 minutes. The tissues were tapped dry and
placed in 100% EtOH for 1 minute, tapped dry then finally de-fatted in m-Xylene
(Thermo Fisher Scientific, Waltham, MA). Following dehydration/de-fatting, tissues
were completely covered by a solution of 5:1 Permount (Thermo Fisher Scientific,
Waltham, MA) and m-Xylene (Thermo Fisher Scientific, Waltham, MA) and
coverslipped with 22 x 50 x 1.5mm VWR micro cover glass (VWR, Radnor, PA), and
allowed to cure at least overnight before storage and imaging.
2.8.1 Stereology
For stereology, StereoInvestigator software 11.04 (Microbrightfield, Williston,
VT) was used to count the number of DCX+ neurons in the left hemisphere of the
immunostained tissue slices. The DCX+ cells in the tissues were identified and
differentiated by the existence of any dendritic process coming from a visible soma
(projecting fiber classification), or the absence of a connecting dendritic process (soma
classification). Additionally, the DCX+ neurons counted were classified based on their
location within the dentate gyrus and classified based on their location within either the
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dorsal or ventral blades of the dentate gyrus (Claiborne, Amaral, & Cowan, 1990;
Desmond & Levy, 1982; Gallitano, Satvat, Gil, & Marrone, 2016). All neuron counts
were doubled to account for the even slices that were processed with different techniques.
This procedure produced an accurate estimate of the total number of DCX+ neurons in
the entire left hemisphere of the hippocampus, but not an accurate estimate of the number
of abGCs of the entire hippocampus as only one hemisphere was examined.
2.8.2 Imaging and image processing procedure:
All DiOlistically labeled tissues (500µm thick slices) were imaged with a Nikon
TE-2000E confocal microscope, using Nikon’s EZ-C1 computing software (v. 3.81b)
(Nikon, Tokyo, Japan). At least three DiOlistically labeled granule cells were imaged
from each animal. All image stacks were stored on an external hard drive until
measurements of soma/branch tracing procedures were completed with NeuroLucida 360
(MicroBrightField, Williston, VT). One neuron from each animal was selected for
analysis with the 3-dimensional reconstructions and tracings analyzed with Sholl
Analysis (Sholl, 1953) procedures with Neurolucida Explorer (MicroBrightField,
Williston, VT) to examine dendritic branching and branch complexity. Dendritic spines
were classified and measured by the software to examine spine length, volume, and head
diameter (Rodriguez, Ehlenberger, Dickstein, Hof, & Wearne, 2008). Dendritic spine
morphology was evaluated using backbone length (in µm), head diameter (µm) and spine
volume (µm3). The measures were defined using previously reported spine measurement
parameters (McLaurin, Li, Booze, Fairchild, & Mactutus, 2018; Roscoe et al., 2014).
Spine backbone lengths of 0.1 to 4.0µm were used for analysis of spine backbone length.
Spine head diameter was constricted to include only spine head diameters between 0 to
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0.8µm for analysis, and volume measures within a range of 0.05µm3 to 0.8µm3 were used
for spine volume analyses. Measurement outputs were exported to Microsoft Excel
(2007) (Microsoft Corporation, Redmond, WA) for data analysis.
All IHC processed tissues were imaged with a Nikon Elipse E800 microscope
(Nikon, Tokyo, Japan), and DCX+ cells were counted based on the established criteria.
Cell number counts were recorded by the StereoInvestigator software and exported to
Microsoft Excel (2007) files.
2.9 STATISTICAL ANALYSIS:
Data analyses were performed using SPSS version 24 (IBM Corp., Somers, NY)
and figures were produced with GraphPad Prism version 5.02 (GraphPad Software, Inc.,
La Jolla, CA). If the data was shown to violate the Analysis of Variance (ANOVA)
sphericity assumption (as determined by Mauchly’s test of Sphericity), GreenhouseGeiser degrees of freedom adjustments were performed, and p-values are reported as pgg
in cases in which the sphericity assumption was violated (Greenhouse & Geisser, 1959).
All p-values were calculated out to at least the 3rd decimal and are reported as exact pvalues. An a priori alpha level of 0.05 was selected and determined statistical
significance in all statistical analyses.
Animal body weights were analyzed with 3-way repeated measures ANOVA,
with genotype, animal sex, and running condition as the 3 factors in the mixed-model
analysis. As expected, animal sex was a significant main effect, so animal sexes were
analyzed separately (2-way repeated measures ANOVA, genotype and running condition
as the factors in the subsequent analysis).
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Female animal estrus cycles were analyzed for both the average length of the
estrus phase of the estrous cycle, and the average number of days for an entire cycle
(estrus to 2nd estrus). These data were analyzed with 2-way ANOVA, with genotype and
running condition as the factors in this analysis to determine if the running condition or
the HIV-1 transgene had any effect on these two parameters of the rat estrous cycle.
The effect of female estrous stage on wheel running behaviors was compiled and
the average running distances during the estrous stage were compared to the average
running distances during non-estrus days (diestrus, metaestrus, and proestrus). These data
averages were statistically analyzed through paired-samples T-tests to compare the effect
of estrus cycle stage on running distances.
Running wheel behaviors were analyzed for genotypic differences on group daily
running distances. 2-way, mixed model (repeated measures) ANOVA was used to
examine running distances. The results of the 2-way mixed models ANOVA predicated
the sexes be analyzed separately (see results), therefore subsequent 1-way mixed model
ANOVAs were performed for each sex. These analyses were performed on the seven
days of habituation to the running wheel, as well as the initial 42 days of wheel running
sessions.
Wheel running bout analysis was performed to examine other potential
differences between the groups in running behaviors which were not apparent in total
wheel running distances. Due to the profound differences in overall running wheel
distances between the sexes, the running bouts were analyzed separately for each sex.
Running bout and IBI data were compared between genotypic groups through one-way
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ANOVA. Additionally, the bout and IBI data were populated into frequency
distributions, and these distributions were analyzed with Chi-Square tests of
Independence to determine if there were significant population difference in the number
and length of the running bouts in the animals, with genotype as the factor in these
analyses.
The number of minutes for the animals to initiate their wheel running was
examined. This measure was determined by the number of consecutive 1-minute bins in
which no wheel revolutions were recorded until the first wheel revolution during each
animal’s first 42 days of wheel running. The data were analyzed (both sexes) through 2way ANOVA, and separately with the male and female animals, due to the pronounced
sex effect in the wheel running behaviors. The separation of the sexes was warranted by
the profound differences in all wheel running measures between the sexes, and the
significant sex effect found in the 2-way ANOVA. These data were analyzed with 1-way
ANOVA, with genotype as the factor in this analysis, and each sex was analyzed
independently.
Maximal running speed (95th percentile) was analyzed between the sexes and
between the genotypes through 2-way ANOVA.
Y maze data was analyzed based on the multiple dependent measures recorded:
Latency to leave the start box (sample trial); latency to make a selection (sample trial);
latency to leave the start box (alternation trial); latency to make a selection (alternation
trial). The dependent measures of latency to leave the starting area and the time it took to
make a successful or erroneous choice of the goal arms was analyzed with repeated

35

measures 3-way ANOVA, with animal genotype, animal sex, and running condition
acting as the between-subjects factors.
Correct/Error ratios (percentage correct) was analyzed with 3-way ANOVA with
identical factors as the latency analyses. The formula for percentage correct is:
Number of correct goal arm alternations/3= X *100
The number of failed trials for each group (separated by animal sex) was analyzed
with Chi-Square analysis of Independence, with running condition and genotype as the
factors in this 2x2 analysis.
Dendritic spine parameters of spine backbone length, spine volume and spine
head diameter were compiled to created population frequencies based on three factors,
genotype, sex and running condition. The distribution frequencies of these measures were
compared through Pearson’s Chi-Square Independence tests (Χ2) with SPSS v. 24 (IBM
corporation, Armonk, NY) for each factor.
Sholl analysis outputs were analyzed with SPSS v.24 (IBM corporation, Armonk,
NY) to compare dendrite length and complexity of the traced neurons. The data was
analyzed with mixed-model 3-way ANOVA, with genotype, sex, and running condition
as the between-subjects factors of this analysis, and the multiple measures of the analyzed
neuron as the within-subjects factor. Post-hoc tests were Bonferroni.
IHC labeled cell counts were analyzed with SPSS v. 24, (IBM corporation,
Armonk, NY) to compare the counts with 4-way ANOVA, with cell location, genotype,
sex, and wheel condition as the four factors in this analysis. As a pronounced location
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effect was shown, subsequent analyses analyzed these neuron counts between the two
locations (dorsal blade vs. ventral blade) separately with 3-way ANOVA analyses with
sex, genotype, and running condition as the factors in these 3-way analyses. When
significant sex effects were found, the analyses used were 2-way ANOVA analysis to
examine the effect of genotype and running condition between the sexes independently.
Wheel running behaviors (total distance, running bout length, and running bout
number) were correlated to DCX+ neuron counts. Running behaviors were also
correlated with spine morphology and spine measurements (spine length, head diameter,
and volume) in the running animals. With variation in wheel running behaviors, it was
expected that there would be a correlation between running behavior intensity and DCX+
counts and spine alterations. For these analyses, the last 7 days of animal wheel running
were averaged, and the means were analyzed with SPSS v. 24 (IBM Corporation,
Armonk, NY). These data were analyzed with Pearson’s correlation (two-tailed) to
determine any correlative effects of wheel running and the number of DCX+ neurons
counted. 5 separate measures (dorsal cell body counts, dorsal fiber, ventral cell body,
ventral fiber, and total cells counted) were correlated to the average daily running
distances in the running animals.
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Representative example of bout data classification
Classified as a Running
Bout
Length = 1minute,
Count=#1

Animal
#

Classified as an interbout interval (IBI)
Length = 8minutes,
Count=#1

Running Bout
Length = 2minutes,
Running Bout
Count=#4
Running Bout
Running Bout
Length =
Length
=
7minutes,
Length
= 2minutes,
4minutes,
Count=#3
Count=#5
Count=#2

Inter-bout
Interval
Length =
2minutes,
Count=#2

Inter-bout
Interval
Length =
2minutes,
Count=#3

Inter-bout Interval
Length = 3minutes,
Count=#4

Figure 2.1: An example from the preliminary running wheel data of animal #25 (Black
Text). Running bouts (Green text) and inter-bout intervals (IBIs, Red text) were
examined for the number of occurrences and mean length of occurrences per each
running session.
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Figure 2.2: The order of the wheel running groups throughout the entire study. With the
described order, both sexes ran during the 19:00 and 20:00 hours for at least 42
consecutive days, to control for potential time-of-day effects on wheel running behaviors.
As the animals were removed from the study, running groups were collapsed in the
configuration above.
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CHAPTER 3
RESULTS
3.1 BODY WEIGHT:
Since the animals arrived at different times throughout the study, body weights
were analyzed with 3-way repeated measures ANOVA, and data was organized by the
number of weighing’s, not the specific date of the weight measure. This was done to
make sure animals were compared equally based on the number of weighing’s and
controlled for differential animal ages. The initial omnibus analysis examined animal
weights over 12 consecutive weekly weighing’s. This analysis showed a significant effect
of genotype F (1,72) =71.62, p≤.0001), animal sex F (1,72) 238.67, p≤.0001) and a
significant genotype * sex interaction F (1,72) =10.92, p=.001). Running condition did
affect the body weights of the animals, however, in the omnibus analysis, this factor did
not reach statistical significance F (1,72) =3.74, p=.057). These significant differences on
the variables (genotype and sex) were expected a priori, and therefore, subsequent
analyses examined the body weight data in each group independently (females and males
separately, controls and HIV-1 Tg separately).
The subsequent analyses of the body weights of the female animals through 2way repeated measures ANOVA (Running Condition and Genotype as the factors of this
analysis) showed that the between-subjects effects on body weights in the animals over
the 12 selected weighing’s were significantly altered due to animal genotype F (1,36)
=11.14, p=0.002) and running condition significantly reduced animal body weight F
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(1,36) =5.13, p=0.030). However, the interaction between these variables was not
significant Genotype * Running Condition F (1,36) =1.74, p=0.196). In the withinsubjects analysis of the female animals, there was a significant day (as a product of
animal growth F(11, 396)=14.79, pgg≤0.0001, and a significant interaction of day and
genotype F(11, 396)=14.79, pgg=0.042, however, the interaction between day and
running condition was not significant (pgg=0.15), and the 3-way interaction of
day*genotype*running condition was not significant (pgg=0.55)
In the analysis of the male animals body weights over the 12 selected weighing’s,
the data showed a significant effect of main between-subjects effect of genotype on the
body weights of the male animals F (1,36) =85.92, p≤ 0.0001), however, the main effect
of running condition was not shown in the male animals F (1,36) =0.09, p=0.773), and
the interaction between genotype * running condition proved not significant F (1,36)
=1.248, p=0.271) in the between-subjects analysis of the body weight data. In the withinsubjects effects of this analysis, there was a significant effect of day F (11,396) =838.35,
pgg≤0.0001), and the interaction of day*genotype was significant F (11,396) =19.59,
pgg≤0.0001). The interactions of day*running condition (pgg=0.22) and the 3-way
interaction of genotype*day*running condition was not significant (pgg=0.61)
3.2 FEMALE ESTROUS CYCLE:
The daily estrous cycle was analyzed over the entirety of the female animal’s life
(mean=139 days, SD=32). These data were analyzed to determine if the wheel running or
HIV-1 transgene had any effect on the length of the estrous cycle or the length of the
estrus stage. In the current study, animals were tracked for a minimum of 78 consecutive
days and a maximum of 191 consecutive days before sacrifice. The 2-way ANOVA

41

showed no significant effects on mean length of the estrus cycle in the HIV-1 transgenic
animals compared to controls F(1,36)=0.45, p=0.506), nor a significant effect on estrous
cycle length due to wheel running condition (sedentary vs. runners) F(1,36)=0.11,
p=0.748). The interaction between genotype and running condition was not significant
F(1,36)=1.27, p=0.267). Further, genotype F(1,36)=0.03, p=0.873) and running
condition F(1,36)=0.57, p=0.454) did not have any significant effect on the mean length
of the estrus stage of the female animals in the current study. The interaction between
genotype and running condition was not significant F(1,36)=0.25, p=0.623) in mean
estrus stage length. These results suggest that neither the HIV-1 transgene nor the wheel
running behaviors affected the natural hormonal fluctuations of female animals in the
current study (Figure 3.38).
3.3 WHEEL RUNNING
3.3.1 Overall Wheel Running:
The habituation data was analyzed with the 3-way mixed model (repeated
measures) ANOVA, with day, genotype and animal sex as the 3 factors in this analysis.
In the omnibus analysis, there was a significant within-subjects effect of day, F(6,
213)=13.10, pgg≤0.0001), however the interaction terms of day*genotype, day*sex, and
the 3-way interaction of day*genotype*sex were not significant. In the between-subjects
effects, genotype significantly affected habituation to the running wheels, F(1,36)=5.19,
p=0.03), as did animal sex F(1,36)=12.22, p=0.001), and the genotype*sex interaction
was significant F(1,36)=4.112 , p=0.05) in this analysis. Subsequent 2-way repeated
measures analyses were performed for each sex independently, with day and genotype as
the factors in the subsequent analyses. In the female animals, the within-subjects effects
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only showed a significant effect of day F(6,108)=8.47, pgg≤0.0001), but the interaction of
day*genotype was not significant. In the between-subjects analysis of the wheel running
of the female habituation data showed a significant effect of genotype on the habituation
to the running wheels in the female animals F(1,18)=6.59, p=0.02). In the male animal’s
2-way repeated measures analysis, there was a significant within-subjects effect of day
F(6,108)=5.04, pgg= 0.01), but the interaction of day*genotype was not significant. In the
between-subjects analysis of the male habituation data, there were no significant effects
of genotype in wheel habituation (Figure 1)
Experimental (post-habituation) wheel running data were analyzed for only the
first 6 weeks (42 days) of each running group. This was done to ensure the data analyzed
were equal on with respect to the time of day in which the running groups had access to
the running wheels. Additionally, wheel running habituation data was analyzed to
examine the progress of the animals “learning” to run in the wheel apparatus. In the
initial omnibus 3-way mixed model (repeated measures) ANOVA, with day, genotype
and animal sex as the three factors in the analysis. The omnibus analysis produced a
pronounced between-subjects main effect of animal sex F(1,36)=27.10, p≤0.0001). Due
to the large effect of animal sex, subsequent analyses separated the sexes to determine if
there was any effect of the HIV-1 transgene on overall wheel running distances. To
determine the effect of the HIV-1 transgene on wheel running behaviors, male and female
animal running distances were analyzed through 2-way mixed model (repeated measures)
ANOVA, with day and genotype as the 2 factors in the analysis. The within-subjects tests
showed that the Day variable (repeated measures) were significant in the female animals
F(41,738)=2.34, pgg=0.037. There was not a significant main effect of genotype in the
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between-subjects analysis F(1,18)=2.00p=0.175. In the male animals, the within-subjects
analysis showed that the main effect of day was significant F(41,738)=4.76, pgg=0.006.
However, there were no other significant differences found in the male animal’s overall
wheel running behaviors.
3.3.2 Wheel Running, Bout Analysis:
Running bout and IBI data from male and female animals were analyzed with
one-way ANOVA with genotype as the factor in this analysis. The analyses of the
number of running bouts in the female animals were significantly different between the
genotypic running groups (F344/N: M=6.18, SD =2.20, HIV-1 Tg: M=6.69, SD =2.40)
when analyzed by 1-way ANOVA F(1, 838)=10.33, p=0.001 (Figure 3.3). The length of
the running bouts was also significantly different between the two genotypic groups in
the female animals (F344/N: M=8.43, SD =7.73, HIV-1 Tg: M=5.85, SD=5.03), F(1,
836)=35.30, p≤0.0001 (Figure 3.4). In the male animals, the number of running bouts
was shown to be (F344/N: M=8.01, SD =2.22, HIV-1 Tg: M=6.40, SD =2.15) was
significantly different between the groups F(1, 838)=114.24, p≤0.0001 (Figure 3.7). The
length of the male running bouts was also significant between genotypic groups (F344/N:
M=3.35, SD =1.14, HIV-1 Tg: M=3.93, SD =2.66) F(1, 838)=17.38, p≤0.0001 (Figure
3.8). The analysis of the IBIs in the animals running behaviors showed pronounced
genotypic differences, similar to that found in running bout analyses, with the female
number of IBIs significantly increased compared to controls (F344/N: M=6.38, SD
=2.22, HIV-1 Tg: M=7.00, SD =2.34) was significantly different between groups in the
ANOVA analyses F(1, 838)=14.98, p≤0.0001 (Figure 3.5), and the length of the IBIs in
the female animals significantly increased (F344/N: M=4.40, SD =4.64, HIV-1 Tg:
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M=5.55, SD=4.50) between groups F(1, 838)=13.24, p≤0.0001 (Figure 3.6). In the male
animals, the number of IBIs during the running sessions was reduced the HIV-1 Tg
animals (F344/N: M=8.33, SD =2.12, HIV-1 Tg: M=6.69, SD =2.14) and significantly
different between the groups F(1, 838)=124.12, p≤0.0001 (Figure 3.9). In the male
animals, there was an increase in the average IBI length of the HIV-1 Tg animals
compared to controls (F344/N: M=5.43, SD =2.12, HIV-1 Tg: M=7.45, SD =4.73) was
significantly different F(1, 838)=63.92, p≤0.0001 (Figure 3.10).

Frequency distributions of the running bout and IBI data were analyzed with ChiSquare analysis of Independence, to examine potential genotypic differences in the bout
and IBIs as a population in whole, there was any effect of the HIV-1 transgene on
motivation or motor function. In the female animals, the frequency distributions of the
number of running bouts were not significantly different Χ2(15, N=840) = 18.46,
p=0.239 (Figure 3.3). However, the average running bout length was significantly
different between the genotypes on a population level Χ2(258, N=838) = 336.36, p=0.001
(Figure 3.4). In IBI frequency distributions, the Chi-Square test of independence showed
significant differences in the groups in the number of IBIs performed by the female
animals Χ2(14, N=840) = 29.52, p=0.009 (Figure 3.5), and in the average length of the
IBIs of the female running animals Χ2(247, N=840) = 307.23, p=0.005 (Figure 3.6). In
the male animals, the number of running bouts was significantly different as a population
Χ2(15, N=840) = 115.14, p≤0.0001 (Figure 3.7) and the average length of the running
bouts were significantly different Χ2(204, N=840) = 288.73, p≤0.0001 (Figure 3.8). In
male IBIs, there were significant differences in the number of IBIs as a population Χ2(14,
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N=840) = 125.23, p≤0.0001 (Figure 3.9), and in the average length of these IBIs Χ2 (253,
N=840) = 366.76, p≤0.0001 (Figure 3.10).

3.3.3 Wheel Running, Latency to Initiate:
The 2-way ANOVA of wheel running latency (genotype and animal sex as the
factors) showed a pronounced sex effect F(1,1676)=28.08, p≤ 0.0001 (Figure 3.11), and
an effect of genotype F(1,1676)=5.98, p=0.015, and the interaction between Sex*
Genotype was not significant F(1,1676)=0.78, p=0.38. One-way ANOVA analysis in the
female animals showed genotype did not significantly impact initiation of the wheel
running behaviors (F344/N Mean=2.89, SEM= 0.224; HIV-1 Tg Mean =2.30,
SEM=0.224) F(1,838)=3.391, p=0.07 (Figure 3.12). In the male animals, it was shown
that the HIV-1 Tg males started their wheel running sooner than controls, similar to that
shown in the female animals (F344/N Mean=1.80, SEM= 0.106; HIV-1 Tg Mean =1.53,
SEM=0.106) F(1,838)=3.33, p=0.07 (Figure 3.12). These results suggest the animals had
similar latency to initiate wheel running and therefore running initiation did not impact
overall wheel running distances.
3.3.4 Wheel Running, Maximal Speed:
Animal maximal running speed analyses produced significant sex effects in the
current sample (males mean=12.25, SEM=1.06, females mean = 21.08, SEM=1.060),
F(1,36)=34.635, p≤0.0001. However, genotype had no significant effect on maximum
running speeds F(1,36)=0.003, p=0.96, and the interaction between sex*genotype was
not significant F(1,36)=1.67, p=0.21 (Figure 3.13). These results suggest the HIV-1
transgene does not affect the physiological ability of the animals to run, and are therefore
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devoid of any motor deficits, despite being significantly physiologically smaller as a
population.
3.4 Y MAZE
3.4.1 Latency to Leave Start Box (Sample Phase)
The 3-way ANOVA of animal latency to leave the start box during the sample
phase showed that animal sex, genotype, and running condition did not significantly
impact the animals behaviors in the Y Maze. Animal sex was not significant
F(1,191)=2.19, p=0.14, genotype was not significant F(1,191)=0.015, p=0.90, and
running condition did not significantly alter this measure F(1,191)=0.17, p=0.68. None of
the interactions were significant: sex*genotype F(1,191)=0.99, p=0.32, sex*running
condition F(1,191)=2.38, p=0.13, genotype*running condition F(1,191)=0.03, p=0.87,
and the three-way interaction was not significant F(1,191)=1.14, p=0.29 (Figure 3.14).
3.4.2 Latency to make choice (Sample Phase)
The 3-way ANOVA of animal latency to make a choice of goal arm in the sample
phase produced several significant main effects. Animal sex showed a significant effect
arm selection, with the female animals making selections sooner than the male animals
(females mean time=19.22, SEM=1.98, males mean= 29.54, SEM=2.11) an effect that
was significant F(1,191)=12.72, p≤0.0001. Genotypic differences were also apparent,
with the HIV-1 Tg animals selecting arms faster than the F344/N animals (HIV-1 Tg
mean = 19.53, SEM=1.956; F344/N mean =29.23, SEM=2.13), a result that was
significantly different between the genotypic groups F(1,191)=11.23, p=0.001. Running
condition also affected the time it took for the animals to make a goal arm selection, with
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the sedentary animals selecting an arm sooner than the running animals (sedentary
mean=20.48, SEM=2.04, runners mean= 28.28, SEM=2.06), an effect that was
significant between the running conditions F(1,191)=7.25, p=0.008. However, the
interactions between these main effects were not significantly different sex*genotype
F(1,191)=1.70, p=0.19, sex*running condition F(1,191)=0.78, p=0.38, genotype *
running condition F(1,191)=0.72, p=0.40, and the three-way interaction was not
significant sex*genotype*running condition F(1,191)=0.10, p=0.75 (Figure 3.14).
3.4.3 Latency to Leave Start Box (Alternation Phase)
The 3-way ANOVA analysis of the latency for the animals to leave the start box
during the alternation phase showed multiple significant effects. In main effects (sex,
genotype and running condition), sex did not reach statistical significance F(1,191)=3.69,
p=0.056, but genotype (F344/N mean= 13.56, SEM=1.59, HIV-1 Tg mean =18.69,
SEM=1.46) was significant F(1,191)=5.67, p=0.02, as well as running condition
(sedentary mean=12.90, SEM=1.52, running mean = 19.35, SEM=1.53) and was
significant F(1,191)=8.94, p=0.003. None of the interactions between these factors
reached statistical significance: sex*genotype F(1,191)=3.51, p=0.62, sex*running
condition F(1,191)=0.63, p=0.43, genotype*running condition F(1,191)=1.89, p=0.17,
and the three-way interaction was not significant F(1,191)=1.41, p=0.24 (Figure 3.14).
3.4.4 Latency to make choice (Alternation Phase)
Statistical analysis of the time it took the animals to make a goal arm selection
during the alternation phase of the Y maze task showed few statistically significant
effects. Animal sex had no impact on the time it took the animals to make a goal arm
selection F(1,190)=0.77, p=0.38, nor did genotype F(1,190)=0.10, p=0.76. However,
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running condition significantly altered goal arm latency, with the running animals taking
longer than sedentary animals to make a selection (sedentary mean = 23.48, SEM=2.42,
running mean = 34.66, SEM= 2.43) which reached statistical significance
F(1,190)=10.63, p=0.001. Additionally, the interaction between animal sex and genotype
proved significant F(1,190)=6.04, p=0.02. All other interactions of these factors did not
reach statistical significance, sex*running condition F(1,190)=2.22, p=0.14,
genotype*running condition F(1,190)=0.37, p=0.54, and the three-way interaction of
sex*genotype*running condition was not significant F(1,190)=0.82, p=0.37 (Figure
3.14).
3.4.5 Accuracy
The 3-way ANOVA of animal accuracy during the Y maze showed no significant
effects in the analysis. Sex F(1,191)=0.01, p=0.91, genotype F(1,191)=0.37, p=0.55,
running condition F(1,191)=0.99, p=0.32. Further analyses showed that the interactions
between any of these factors were also not significant sex*genotype F(1,191)=2.66,
p=0.11, sex*running condition F(1,191)=0.02, p=0.89, genotype*running condition
F(1,191)=1.48, p=0.23, and the three-way interaction was not significant F(1,191)=0.02,
p=0.89 (Figure 3.15).
3.4.6 Failed Trials
The Chi-Square analysis of Independence of the number of failed trials showed no
significant differences in the number of failed trials in the female animals due to
genotype, nor running condition Χ2(6, N=4) = 8.32, p=0.24. In the male animals, there
was again no difference in the number of failed trials due to running condition or
genotype Χ2(6, N=4) = 8.32, p=0.24.
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3.5 HISTOLOGY DIOLISTICALLY LABELED ABGCS
3.5.1 Spine Measures
Dendritic spine length (µm), head diameter (µm) and volume (µm3) populations
were analyzed with Chi-Square (Χ2) analysis of independence tests to determine if the
spine measures varied in the animals based on genotype, animal sex, and/or running
condition.
3.5.2 Spine Backbone Length (µm)
These analyses suggested there were significant differences due to animal
genotype in backbone spine length Χ2(368, N=266,754) = 2093.26, p≤0.0001. There was
also a significant population shift due to animal sex Χ2(368, N=266,754) = 1162.94,
p≤0.0001, and a pronounced, significant effect of running condition on spine backbone
length Χ2(368, N=266,754) = 2292.03, p≤0.0001 (Figures 3.16 & 3.17).
3.5.3 Spine Head Diameter (µm)
Spine head diameter showed a significant population shift in spine measures due
to animal genotype Χ2(80, N=257,642) = 611.56, p≤0.0001, with a reduction in head
diameter in the HIV-1 Tg animals compared to F344/N controls. When examining spine
head diameter differences due to animal sex, significant population shifts were shown by
these analyses Χ2(80, N=257,642) = 589.62, p≤0.0001, and also due to running condition
Χ2(80, N=257,642) = 1811.32, p≤0.0001(Figures 3.18 & 3.19)
3.5.4 Spine Volume (µm3)
There was a significant effect of genotype on spine volumes in the dentate gyrus
granule cells analyzed Χ2(76, N=193,415) = 18974.56, p≤0.0001. In spine volume when

50

analyzed between the sexes, there was a significant population shift in spine volume
Χ2(76, N=193,415) = 3268.87, p≤0.0001 and due to running condition Χ2(76,
N=193,415) = 4804.74, p≤0.0001 (Figures 3.20 & 3.21)
3.6 SHOLL ANALYSES
Sholl analyses of the 80 DiOlistically labeled selected neurons maximum radius
was not significantly impacted by running condition, sex, nor genotype. However,
running condition did nearly reach significance on the maximum radius of the Sholl
analyses F(1,72)=3.39, p=0.07 (Figure 3.22). The interaction terms were not significant
in this omnibus analysis of maximum radius reached. Additionally, when the total
number of intersections was examined, there were no significant effects due to the three
factors, and no interactions proved significant. In the total lengths of the dendrites
examined, only genotype approached significance F(1,72)=3.34, p=0.07, no other factors
were significant, and the interaction of these factors was not significant. In the dendritic
total surface area measured by the Sholl analysis, there was a significant effect of wheel
running F(1,72)=4.19, p=0.04, but no other factors significantly altered this parameter,
and none of the interaction terms were significant. Finally, in the analysis of the average
diameter of these dendrites analyzed, only sex reached statistical significance
F(1,72)=6.95, p=0.01, and the sex*genotype interaction approached significance
F(1,72)=2.70, p=0.10.
The Sholl analyses were analyzed again with each sex independently, and while
there were no significant effects in these measures (maximum radius, total intersections,
total dendritic length, total dendritic surface area, and average dendrite diameter) in the
male animals. In the female animals, significant differences were found in the factors of
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genotype and running condition. Specifically, in the female animals, running condition
significantly increased the maximum radius (i.e.-maximum length) (sedentary
mean=172.50, SEM=7.58, runners mean= 157.00, SEM=7.58) F(1,36)=4.02, p=0.05.
There were no significant differences in total intersections in the female animals from
either of the factors, but in total dendritic length, there was a nearly significant effect of
the HIV-1 transgene (F344/N mean= 874.70, SEM=85.49, HIV-1 Tg mean =670.78,
SEM=85.49) which approached significance F(1,36)=2.85, p=0.10. Additionally,
genotype approached significance in the total dendritic surface area measured (F344/N
mean= 4635.92, SEM=514.57, HIV-1 Tg mean =3391.83, SEM=514.57) was significant
F(1,36)=2.92, p=0.09. Finally, in average dendritic diameter in the female animals, no
single factor proved significant, however the interaction between genotype and running
condition was significant in the analysis of this measure (F344/N sedentary mean= 1.47,
SEM=0.11, F344/N runner mean= 1.78, SEM=0.11, HIV-1 Tg sedentary mean =1.61,
SEM=0.11, HIV-1 Tg runner mean=1.42, SEM=0.11) was significant F(1,36)=5.04,
p=0.03 in the female animals.
3.7 DOUBLECORTIN (DCX) IMMUNHISTOCHEMISTRY
3.7.1 Dorsal Vs. Ventral Blade of the Dentate Gyrus Counts
Initial analysis of the number of DCX+ neurons in the dentate gyrus utilized 4way ANOVA analyses to determine if there was a significant difference in the location of
the DCX+ cell body defined and in the projecting fiber neurons in the current study.
Location, genotype, sex, and running condition were used as the factors in these two
separate analyses. Importantly, location (dorsal vs. ventral blade of the dentate gyrus)
was significant in this analysis of cell bodies counted (dorsal mean = 59.00, SEM =3.86,
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ventral mean = 82.68, SEM = 3.86) F(1,126)=18.85, p≤0.0001 (Figure 3.23). When the
4-way ANOVA analysis (identical factors) of the projecting fibers was performed, there
was a significant effect of neuron location (dorsal mean = 103.46, SEM =6.72, ventral
mean = 156.60, SEM = 6.72) F(1,126)=31.30, p≤0.0001 (Figure 3.23).It was due to this
pronounced location effect that all other analyses were performed with the location of the
DCX+ neurons analyzed separately (dorsal vs. ventral blades analyzed independently).
3.7.2 Cell body counts
3-way ANOVA analyses were used to examine the number of cell bodies (DCX
positive signals without any identifiable dendritic projections) in the animals, separated
by the location of these abGCs (dorsal vs. ventral blades of dentate gyrus). In the dorsal
blade, the analysis elucidated a significant sex effect on the number of cell body counts
(female mean = 41.00, SEM=4.75, male mean = 70.70, SEM=4.75) F(1,72)=19.57,
p≤0.0001 (Figure 3.24). There was not a significant effect on due to genotype or running
condition in the omnibus 3-way analysis, and the 2-way and 3-way interactions were not
significant.
In the 3-way analysis of the DCX+ cell bodies in the ventral blade, there was a
significant effect off sex (female mean = 59.10, SEM=5.77, male mean = 99.75,
SEM=5.77) F(1,72)=24.86, p≤0.0001 (Figure 3.25), and a nearly significant effect of
genotype (F344/N mean = 87.20, SEM=5.77, HIV-1 Tg mean = 71.65, SEM=5.77)
F(1,72)=3.64, p=0.06. In this analysis, there were no significant 2-way or 3-way
interactions which proved significant. Therefore, in both analyses of the cell bodies
counted, a pronounced sex effect was shown. For this reason, subsequent analyses were
performed with each sex analyzed separately with 2-way ANOVAs.
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The follow-up analyses of the dorsal blade DCX+ abGCs cell body counts in
female animals, only running condition even approached statistical significance
(sedentary mean = 39.9, SEM=4.72, runner mean = 42.1, SEM=4.72) F(1,36)=3.02,
p=0.09. Furthermore, the analysis of the cell bodies counted within the ventral blade of
the dentate gyrus did not produce any significant effects in the main factors of genotype
and running condition, and the interaction of these factors was not significant.
In a subsequent analysis of the male animal’s cell body counts, in the dorsal blade
of the dentate gyrus, there were no significant effects found of genotype or running
condition, and the interaction of these terms was not significant. However, in the 2-way
ANOVAs of the ventral blade of the dentate gyrus, genotype significantly impacted the
number of DCX+ granule cells of the dentate gyrus (F344/N mean =111.90, SEM=7.47,
HIV-1 Tg mean=87.60, SEM=7.47) F(1,36)=5.29, p=0.03 (Figure 3.26). The other factor
(running condition) did not reach significance, and the interaction between genotype*
running condition did not reach statistical significance.
3.7.3 Projecting Fiber Counts
The 3-way ANOVA analysis of the number of projecting fibers (DCX+ cells with
at least one defined dendritic projection) were separated by location (dorsal vs. ventral
blade) and analyzed. These analyses of the dorsal blade produced a significant effect
(female mean = 70.75, SEM=9.13, male mean = 122.40, SEM=9.13) F(1,72)=16.02,
p≤0.0001 (Figure 3.27). Both genotype (F344/N mean = 108.20, SEM=9.13, HIV-1 Tg
mean = 84.95, SEM=9.13) F(1,72)=3.25, p=0.08, and the interaction of genotype*sex
F(1,72)=3.33, p=0.07 nearly reached statistical significance.
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The 3-way ANOVA analysis of the ventral projection fibers again produced a
significant effect of animal sex (female mean = 102.15, SEM=9.88, male mean = 193.35,
SEM=9.88) F(1,72)=42.61, p≤0.0001 (Figure 3.28), and genotype approached statistical
significance (F344/N mean = 153.40, SEM=9.88, HIV-1 Tg mean = 136.10, SEM=9.88)
F(1,72)=2.78, p=0.10. Running condition and the interactions did not reach statistical
significance in ventral blade DCX+ projection fiber counts in this sample.
In subsequent 2-way ANOVA analyses of the counted DCX+ projecting fibers
abGCs, in the female animals, in the dorsal blade of the dentate gyrus, only running
condition nearly reached statistical significance (sedentary mean = 60.20, SEM=8.94,
runner mean = 81.30, SEM=8.94) F(1,36)=2.78, p=0.10. No other factors, nor any of the
interaction terms approached statistical significance in female dorsal blade projecting
fiber counts.
In the 2-way analysis of DCX+ projection fibers in the female animal’s ventral
blades of the dentate gyrus did not show any significant main effects (genotype and
running condition) nor did the interaction term of these factors reach significance.
In the male animals, the 2-way ANOVA analysis of the DCX+ projecting fibers
of the dorsal blade of the dentate gyrus, only genotype reached statistical significance
(F344/N mean = 145.80, SEM=15.91, HIV-1 Tg mean = 99.00, SEM=15.91)
F(1,36)=4.33, p=0.05 (Figure 3.29). Running condition nor the interaction term was
statistically significant.
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The analysis of the ventral blade of the dentate gyrus DCX+ projection fibers in
the male animals; there was neither a significant effect of genotype, running condition,
nor a significant interaction between these factors.
3.7.4 Total Cell Counts
The total number of DCX+ cells in the dentate gyrus were analyzed with 3-way
ANOVA initially, with sex, genotype and running condition serving as the three factors
in these analyses. These analyses ignored the abGC classification and the location of
these abGCs to better understand the effect(s) of the sex, wheel running and genotype on
the production of these abGCs in the entire dentate gyrus. In the 3-way ANOVA analysis,
only sex reached statistical significance (female mean = 273.00, SEM=26.06, male mean
= 486.20, SEM=26.06) F(1,72)=33.46, p≤0.0001 (Figure 3.30), with genotype nearly
reaching statistical significance (F344/N mean = 414.95, SEM=26.06, HIV-1 Tg mean =
344.25, SEM=26.06) F(1,72)=3.68, p=0.06. No other factors, nor did any of the
interaction terms reach statistical significance. Due to the robust sex effect, subsequent 2way ANOVAs were performed in the sexes independently in total abGCs counted.
In the female animals, the number of total DCX+ neurons counted was not
significantly affected by genotype or running condition, and the interaction of these terms
did not reach statistical significance. However, in the male animals, the 2-way ANOVA
produced a significant effect of genotype (F344/N mean = 549.40, SEM=43.74, HIV-1
Tg mean = 423, SEM=43.74) F(1,36)=4.18, p=0.05 (Figure 3.31). Running condition and
the interaction of running condition * genotype did not reach statistical significance.
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3.7.5 Correlations between wheel running distances and DCX+ cell counts
Pearson Correlation analyses (two-tailed) were performed to determine any
correlations between wheel running behaviors (final 7 days mean distances, number of
running bouts, and average bout length). The number of running bouts was significantly
positively correlated with the number of dorsal cell bodies in the whole population of
running animals (r=0.48, n=37, p=0.003) (Figure 3.32), and the number of dorsal
projecting fibers (r=0.39, n=37, p=0.02) (Figure 3.33). Ventral dentate gyrus cell counts
were not significantly related to the number of running bouts, however, the total counts of
all DCX+ abGCs were significantly positively correlated with the mean number of
running bouts (r=0.36, n=37, p=0.03) (Figure 3.34). When analyzed separately between
the sexes, in the female animals there was a significant correlation between the average
running distance bouts and ventral dentate gyrus cells with projections counted (r=0.57,
n=19, p=0.01) (Figure 3.35) and total cells counted (r=0.51, n=19, p=0.03) (Figure 3.36).
In the male animals, there was a significant positive correlation between the number of
running bouts and the number of dorsal cell bodies counted (r=0.51, n=18, p=0.03)
(Figure 3.37). No other significant correlations were shown in these data.
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Figure 3.1: Wheel running habituation data. Overall, all groups increased their running
distances over the 7 days of habituation, at nearly equal rates. However, there was a
significant reduction in wheel running the female HIV-1 Tg animals compared to F344/N
control animals. In the male animals, there were no significant differences in overall
wheel running between the groups.
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Figure 3.2: Wheel running for the first 42 days of the experimental collection phase of the
current study. There are pronounced differences between the sexes in their wheel running
behaviors, with the males running significantly less than the female animals.
Additionally, over the 42 days, females increased their running distances while the males
slightly reduced their running distances over the first 42 days of wheel running.
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Figure 3.3: Female number of running bouts/session cumulative distribution. In the
current dissertation, it was shown that the HIV-1 Tg animals had significantly increased
running bouts during their sessions (as shown through ANOVA analysis) compared to the
F344/N animals, however, this effect was not significant in Chi-Square analyses.
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Figure 3.4: Female mean running bout Length/session cumulative distribution. These data
showed that the HIV-1 Tg animals ran for shorter bouts compared to the F344/N controls,
a result that was significant in both ANOVA and Chi-Square analyses.
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Figure 3.5: Female Interbout Intervals (IBI) per session cumulative distribution. Analysis
of this data showed significantly longer IBIs in the HIV-1 Tg animals compared the
F344/N controls. This difference was also shown with Chi-Square analyses. Increase IBI
lengths are suggestive of an alteration in motivation for wheel running in the HIV-1 Tg
animals.
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Figure 3.6: Female interbout interval (IBI) mean length cumulative distribution. The
analysis of these data showed significantly longer IBI length in the female HIV-1 Tg
animals compared to F344/N controls. Additionally, the Chi-Square analysis of
independence showed the data distributions were significantly different in this sample.
Increased IBI length suggests a dysregulation of motivation for the naturally rewarding
wheel running.
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Figure 3.7: Male number of running bouts/session cumulative distribution. The number
of running bouts per session was significantly reduced in the HIV-1 Tg animals
compared to F344/N control animals in ANOVA analyses. Additionally, the Chi-Square
analysis showed significant population shifts (leftward) in the HIV-1 Tg animals
compared to controls.
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Figure 3.8: Male mean running bout length cumulative distribution. The data showed that
the HIV-1 Tg males had increased running bout lengths compared to F344/N controls.
This effect was significant in both ANOVA and Chi-square analyses. This result, coupled
with the reduction in the number of running bouts in the male animals presumably
accounted for the similar (non-significant) total running distances in the male animals.
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Figure 3.9: Male number of Interbout Intervals/session cumulative distribution. There
was a significant reduction in the number of IBIs in the male HIV-1 Tg animals
compared to controls. This difference was significant in both ANOVA and Chi-Square
analyses, and this effect may account for the similar total running distances in the HIV-1
and F344/N controls.
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3.10: Male Interbout Intervals (IBI) mean length cumulative distribution. There was a
significant increase in the mean length of the IBIs in the male HIV-1 Tg animals
compared to F344/N controls in this sample, as shown by significant ANOVA and ChiSquare analyses.
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Figure 3.11: Latency to first wheel revolution between animal sexes. The ANOVA
analysis of the latency to initiate the first wheel revolution showed significant sex
differences, with the male animals initiating there first revolution significantly earlier
than the female animals.
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Figure 3.12: Latency to initiate the first wheel revolution. The 2-way ANOVA analysis of
the latency to intiate the first wheel revolution showed significant effects of both animal
sex, and genotype, with males starting their first wheel revolution sooner than the female
animals, and the HIV-1 Tg animals starting earlier than F344/N control animals.
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Figure 3.13: Box and whisker plot (full range) of animal maximal running speed (95th
percentile) of the running groups, separated by animal sex (females left half) and
genotype (F344/N=blue shades, HIV-1 Tg=red shades). The ANOVA analysis of this
data showed significant sex differences in maximum running speed attained, but no
significant differences in genotype.
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Figure 3.14: Latency to leave the start box and make a selection of arm in the Y maze
(Controls= blue; HIV-1 Tg=red; Males are the lighter shades of their respective genotype
color).
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Figure 3.15: Animal accuracy in correct alternation in the spontaneous alternation
procedure in the Y maze. There were no significant differences in animal sex, genotype,
or running condition on the accuracy of the animals in the Y maze spontaneous
alternation task.
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Figure 3.16: Female Dendritic Spine Backbone Length distribution frequency
distribution. Chi-Square analysis of Independence showed significant effects of running
condition (a rightward shift in runners) and genotype (a rightward shift in HIV-1 Tg
females compared to F344/N controls). These results suggest wheel running can
significantly increase dendritic spine lengths compared to sedentary animals.
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Figure 3.17: Male Dendritic Spine Backbone Length Distribution frequency distribution.
There was a significant effect of wheel running on spine length, which was more
pronounced in the HIV-1 Tg males compared to controls in the Chi-Square analysis of
Independence. Additionally, there was a significant reduction in spine length (leftward
shift) in the HIV-1 Tg animals compared to F344/N controls. This result suggests wheel
running can increase spine length in animals, regardless of genotype.

74

Spine Head Diameter:Freq. dist. (Female)
55
50

Frequency (%)

45
40
35

F344/N Females Sed
F344/N Females Run
HIV-1 Tg Females Sed
HIV-1 Tg Females Run

30
25
20
15
10
5

0.80

0.75

0.70

0.65

0.60

0.55

0.50

0.45

0.40

0.35

0.30

0.25

0.20

0.15

0.10

0.05

0.00

0

Spine Head Diameter (m)
Figure 3.18: Female Dendritic Spine Head Diameter frequency distribution. There was a
significant increase in spine head diameter in the running female animals compared to
sedentary animals. Additionally, there was a significant leftward shift in dendritic spine
head diameter HIV-1 animals compared to F344/N controls. These data were shown to be
significant through Chi-Square analysis of Independence statistical tests.
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Figure 3.19: Male Dendritic Spine Head Diameter frequency distribution. There was a
significant effect of genotype (HIV-1 Tg reduction, leftward shift), and a rightward shift
in running animals compared to controls. These results suggest wheel running is capable
of increasing spine head diameter, even in HIV-1 Tg animals. These data were analyzed
through Chi-Square analysis of Independence tests.
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Figure 3.20: Female Dendritic Spine Volume frequency distribution. In the female
animals, there was a significant difference in dendritic spine volume measures, with a
leftward shift due to animal genotype, and a rightward shift due to running condition in
the female animal granule cell dendritic spine measures. These data were analyzed with
Chi-Square analysis of Independence tests.
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Figure 3.21: Male Dendritic Spine Volume frequency distribution. There were significant
population differences in spine volume in the male animals as analyzed by Chi-Square
analysis of Independence tests, with animal genotype significantly reducing spine volume
(leftward shift), yet, wheel running significantly increased spine volume (rightward shift)
in both the F344/N and HIV-1 Tg male animals.
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Figure 3.22: Sholl Analysis of the number of intersections/radii, between the running
condition groups. The number of interections/radii was significantly increased in running
animals compared to sedentary animals. The number of intersections at distal radii, was
increased by wheel running, and further, increased the number of intersections, therefore
creating more complex dendritic branching in the distal ends of the labeled granule cells
of the dentate gyrus.
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Figure 3.23: DCX+ cell counts dependent on classification and location within the
dentate gyrus. There was a significant effect of location on the abGCs found within the
dentate gyrus, with more DCX+ neurons counted in the ventral blade compared to the
dorsal blade of the dentate gyrus. Additionally, there was a significant increase in the
number of more mature, projecting fiber DCX+ neurons in both the dorsal and ventral
blades of the dentate gyrus compared to the less mature cell bodies counted.
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Figure 3.24: Dorsal DCX+ Cell body counts. In the dorsal blade of the dentate gyrus,
there was a significant effect of animal sex on the number of cell bodies (no dendrites)
found within the left hemisphere of the dendate gyrus, with females having significantly
fewer DCX+ cell bodies compared to the male animals.
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Figure 3.25: Ventral DCX+ Cell body counts. There was a significant reduction in the
number of DCX+ cell bodies found within the ventral blade of the dentate gyrus in the
female animals compared to the male animals. Male animals had nearly double
(mean=99.75) the number of DCX+ neurons in the ventral blade of the dentate gyrus
compared to female animals (mean=59.1).
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Figure 3.26: Male Ventral Cell body counts separated by genotype. There was a
significant reduction in the HIV-1 Tg male animals in the number of DCX+ neurons
within the ventral blade of the dentate gyrus compared to F344/N control animals. These
data support the initial hypothesis of reduced abGCs in the HIV-1 Tg animals due to
chronic HIV-1 viral protein expression.
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Figure 3.27: Dorsal Projecting Fiber counts. There was a significant reduction in the
number of projection fiber DCX+ neurons of the dorsal dentate gyrus due to animal sex,
with the males having substantially more DCX+ abGCs with a dentritic process
protruding from the cell body.
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Figure 3.28: Projection fiber counts in the ventral dentate gyrus. Similar to what was
observed in the dorsal blade of the dentate gyrus (Figure 3.27), there was a significant
reduction in the female animals compared to the male animals in the number of DCX+
abGCs with a dendritic projection found within the ventral blade of the dentate gyrus.
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Figure 3.29: Male Projection fibers in the dorsal dentate gyrus. A significant reduction of
DCX+ projecting fibers in the dorsal blade of the dentate gyrus was shown in the HIV-1
Tg male animals compared to F344/N controls. This finding supports the hypothesis that
chronic HIV-1 viral proteins would reduce the number of DCX+ neurons within the
dentate gyrus, but only in the male animals, similar to that shown in Figure 3.26.
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Figure 3.30: Total DCX+ Cell counts of the entire dentate gyrus. In total DCX+ cells
counted within the dentate gyrus, there was a significant reduction in the number of
abGCs counted due to animal sex, with the males having nearly 2-fold as many DCX+
abGCs in the dentate gyrus compared to the female animals.
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Figure 3.31: Male total cell counts of the dentate gyrus. In the male animals, there was a
significant reduction in the total number of DCX+ neurons within the dentate gyrus due
the HIV-1 transgene and chronic HIV-1 viral protein expression. This result supports the
initial hypothesis that HIV-1 viral proteins would reduce neurogenesis in the HIV-1 Tg
animals compared to controls.
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Figure 3.32: Correlation between the number of running bouts and the number of DCX+
abGC cell bodies counted in the dorsal dentate gyrus. There was a significant correlation
between the number of running bouts and the number of DCX+ cell bodies counted
within the dorsal blade of the dentate gyrus, indenpendent of animal genotype and animal
sex.
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Figure 3.33: Correlation between the number of running bouts and the number of DCX+
abGC projecting fibers found in the dorsal dentate gyrus. There was a significant
correlation between the number of running bouts during the running session in the
running animals and the number of dorsal projecting fibers in the dentate gyrus.
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Figure 3.34: Correlation between the number of running bouts and the total counted
DCX+ abGCs of the dentate gyrus. There was a significant correlation between the total
number of abGCs of the dentate gyrus and the number of running bouts in the running
animals. This data supports the initial hypothesis that wheel running would increase the
total number of DCX+ abGCs within the dentate gyrus.
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Figure 3.35: Correlation between last 7 days of wheel running mean distances and
number of DCX+ projecting fibers within the ventral blades of the dentate gyrus in the
female animals. There was a significant correlation between the running distances in the
female animals and the number of DCX+ projecting fibers in the ventral dentate gyrus.
This result supports the hypothesis that with increased wheel-running distances, there was
increased abGC proliferation, at least within the ventral blade of the dentate gyrus, and
only in the female animals.
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Figure 3.36: Correlation between the total DCX+ cells counted and mean running
distances in the female animals. There was a significant increase in the number of DCX+
abGCs within the dentate gyrus in the female animals based on the wheel running
distances. This result supports the hypothesis that wheel running would increase granule
cell proliferation in the dentate gyrus with increased wheel-running distances (at least in
the female running animals). This result included both genotypes, but was only shown in
the female animals, and not found in the male animals.
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Figure 3.37: Correlation between the number of dorsal DCX+ cell bodies counted in the
dentate gyrus and the mean number of running bouts in the male animals. There was a
significant correlation between the number of wheel running bouts and the number of
dorsal cell bodies counted in the male animals. This correlation in the female animals did
not reach statistical significance.
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Figure 3.38: Estrous Cycle length (A) and Estrus Stage Length (B). The daily
tracking estrous showed no significant differences in the length of the estrous cycle of the
two genotypic groups (A), nor was there an effect due to wheel running in the female
animal estrous cycle length. Further, genotype nor running condition affected the number
of days the female animals spent in the estrus stage (B).
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CHAPTER 4
DISCUSSION

Subgranular zone dentate gyrus neurogenesis in the HIV-1 Tg rat was examined
in the current study under both the influence and absence of physical activity. To evaluate
neurogenesis, doublecortin was used to evaluate the number of abGCs in the dentate
gyrus of the hippocampus and examine the location and integration of these newborn
neurons within the dorsal and ventral blades of the dentate gyrus in the rat hippocampus.
Granule cells of the dentate gyrus were labeled with diOlistic labeling to identify and
measure dendritic spines with Neurolucida 360 software and dendrite length through
Sholl analyses. Wheel running was used to promote neurogenesis, as well as examine the
motivation for wheel running in the HIV-1 Tg rat. Both sexes were used in the current
study, and sex differences were elucidated in wheel running behaviors, the creation of
granule cells, and dendritic spines of the dentate gyrus. The spontaneous alternation Y
maze was used to assess cognitive abilities in the animals following sustained wheel
running. DiOlistic labeling was used to evaluate the structural and dendritic spine
development in the HIV-1 Tg rat and determine the impact of sustained physical activity
on these cells. Dentate gyrus granule cells are vital components of the subcortical
trisynaptic pathway within the hippocampus, a structure which has been shown to be vital
in working memory function (D. S. Olton & Feustle, 1981; D. S. Olton et al., 1978,
1982).
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The most pronounced and consistent finding from the current project was
substantial sex differences in wheel running behaviors and neuroanatomical dendritic
spine measures. Significant sex differences were shown in voluntary wheel running
behaviors, specifically in overall wheel running distances, with female animals running
2-3 fold further in the running sessions compared to the male animals. This result is not
unexpected, as female animals have been known to run greater distances for nearly 90
years (Shirley, 1929) a result which has been shown in multiple more contemporary
studies (Boakes, Mills, & Single, 1999; Eikelboom & Mills, 1988; Tokuyama, Saito, &
Okuda, 1982). The microstructural bout analyses of the wheel running showed the
reduction in motivation was not as pronounced in the female HIV-1 Tg animals
compared to the male animals, with the HIV-1 Tg females actually producing more
running bouts per each daily 66 mintue session. In the female HIV-1 Tg animals there
was only a slight (yet significant) reduction in mean running bout length compared to
their F344/N counterparts. In contrast, the male HIV-1 Tg animals exhibited large
reductions in the number of running bouts per session, yet while producing significantly
longer running bouts compared to F344/N controls. Animal sex also had pronounced
effects on histological measures of the granule cells of the dentate gyrus, in both the
DCX+ abGC counts as well as the dendritic spine measures of the labeled granule cells of
the dentate gyrus, with the female dentate gyrus having significantly fewer DCX+
granule cells compared to the male animals. The differences in neurogenesis between the
sexes may be in part due to different levels of circulating hormones between the sexes
(Barker & Galea, 2008; Farinetti et al., 2015). In overall wheel running distances, the
present study did not establish any significant differences between the genotypic groups,
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but significant reductions in the number of wheel running bouts in the male HIV-1 Tg
animals. The reduction in the number of running bouts in the HIV-1 Tg males and
reduction in running bout lengths (both sexes) are suggestive of an altered motivation
profile in the HIV-1 Tg animals compared to controls.
Unfortunately, the guiding hypothesis of the current study that wheel running
would improve cognition and working memory in the HIV-1 Tg animals was not
supported by the data, as there was no significant improvement in the Y maze
spontaneous alternation task in the HIV-1 Tg animals due to wheel running. This finding
may be attributed to a lack of sensitivity in the Y maze task, and perhaps other
improvements in cognition were produced by the wheel running but were not tested in
this Y maze procedure. This is not the only study that has shown a lack of working
memory improvement following physical activity (Acevedo-Triana, Rojas, & Cardenas
P., 2017), however the Acevedo-Triana group used forced physical activity, the T maze,
and for much a much shorter access to the physical activity. In the current study, perhaps
increasing the length of the ITI would have produced greater (more detectable) effects on
cognition following wheel running. It was initially hypothesized to observe an
improvement in the Y maze task as it has been established wheel running in mice
improves memory function in tasks such as the Y maze (Chen et al., 2006; Van der
Borght, Havekes, Bos, Eggen, & Van der Zee, 2007; Wei-Ping et al., 2006); however the
Y maze protocol in these studies was different than the current spontaneous alternation
task used in the current study.
While it was shown that wheel running distances were correlated with the number
of DCX+ neurons of the dentate gyrus, this relationship was only established in the
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female animals and was not significantly correlated in the male animals. Again, this
result may be a product of differential levels of circulating ovarian hormones such as
estrogens, progestins and adrenal/testicular androgens (Barker & Galea, 2008; Farinetti et
al., 2015). Additionally, there was substantial reductions in the number of DCX+ neurons
in the male HIV-1 Tg animals compared to F344/N controls. This result was expected as
the HIV-1 viral proteins Tat (Fan et al., 2016) and gp120 (M.-H. Lee et al., 2013) have
been shown to inhibit neurogenesis in the dentate gyrus independently. The chronic
expression of these two viral proteins in our HIV-1 Tg rat model (J. Peng et al., 2010;
Vigorito et al., 2015) presumably affected the proliferation and/or survival of the abGCs
in the current study, significantly in the male animals.
Wheel running had no dramatic effect on the proliferation and survival of the
abGCs, there were significant effects of wheel running on dendritic spines on the granule
cells of the dentate gyrus. However, the current study, wheel running significantly
increased dendritic spine length, head diameter, and volume in both sexes and in both
genotypes compared the sedentary controls. The increase in spine measures suggest that
running may be an effective therapeutic for synaptodendritic damage from HIV-1 viral
proteins, and this effect has also been established in healthy F344/N controls. These data
support the second and third hypotheses of the current study. However, wheel running
did not fully compensate for HIV-1 spine alterations (significant genotype effect), the
improvement in spine measures in the HIV-1 Tg animals suggests wheel running is
capable of promoting spine growth and maturation, improving synaptic integrity.
Sholl analyses (Sholl, 1953) of the diOlisitically labeled granule cells showed that
wheel running was able to not only improve dendritic complexity (increased distal
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branching), but was also able to increase dendritic length of granule cells in the female
animals. Furthermore, wheel running significantly increased dendritic surface area
compared to sedentary animals in the female animals, but not in the male animals. These
results suggest wheel running has differential effects on granule cells of the dentate gyrus
between the sexes, and future studies should focus on these sex differences to get a better
understanding on the mechanism for these differential changes between the sexes.
In the current study, only voluntary wheel running was used to produce more
abGCs of the dentate gyrus and to promote dendritic spine growth. However, voluntary
wheel running is under the influence of animal intrinsic motivation, and less motivated
such as that observed in the HIV-1 Tg animals (Bertrand, Mactutus, Harrod, Moran, &
Booze, 2018; Cranston, 2016). However, in the current study, the reduction in motivation
in the HIV-1 Tg animals was only observed in the male animals, and not in the female
animals, as determined by the microstructural bout analyses. Other authors have utilized
forced wheel running to promote neurogenesis (Acevedo-Triana et al., 2017; Chen et al.,
2006; W.-P. Xu et al., 2006), however, this particular technique is capable of producing
stress in the animals, an established inhibitor of neurogenesis (Bustamante et al., 2010;
Lemaire, Koehl, Le Moal, & Abrous, 2000; Morais et al., 2014), especially prenatal
stress. Other research has also used ladder climbing tasks to promote physical activity
that is resistance-based (Kim, So, Choi, Kang, & Song, 2015; Nokia et al., 2016; Tang et
al., 2016; Tang, Kang, Yin, Sun, & Fan, 2017). However, as Nokia et al., 2016 found,
aerobic exercise was the strongest promoter of SGZ neurogenesis (Nokia et al., 2016).
The increase in distal branching of the dentate gyrus granule cells are the
branches/spines that receive input from the lateral perforant pathway from the entorhinal
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cortex (Steward, 1976). The increase in distal branching of the granule cells of the
dentate gyrus suggest these granule cells are integrated into the perforant pathway, and
the axons of these granule cells provide the communication pathway (mossy fiber
pathway) to the CA3 pyramidal cells. It is believed these granule cells that receive input
from the lateral entorhinal cortex are vital for the processing of non-spatial information
(Masurkar et al., 2017), while the projections from the medial entorhinal cortex provide
information to the pyramidal cells of the hippocampus and are involved in spatial
components of memory (i.e.-spatial learning/memory and place cells).
The current study provided evidence that voluntary wheel running does not affect
estrous cyclicity in F344/N controls or HIV-1 Tg female animals. Additionally, it was
shown that the length of the estrus stage was not affected by the presence of the HIV-1
transgene, and wheel running did not affect the length of the estrus stage. This result is
important to establish that wheel running alterations that are dependent upon estrus
cycling are not present in the current study. It is well established that wheel running is
affected by estrous cycles in female rats, verifying that the results were not differentially
influenced by altered estrous cyclicity due to the presence of the HIV-1 transgene, and
that wheel running did not affect estrous cycles in the HIV-1 Tg females, nor in the
F344/N controls.
The influence of circulating gonadal hormones in the current study improved
wheel running motivation in the female HIV-1 Tg animals. Previously, the lab has
reported reductions in the number of running bouts in ovariectomized female HIV-1 Tg
animals compared to F344/N controls (Cranston, 2016), considered a valid measure of
motivational loss, or apathy (Hoffman & Newland, 2016; J. E. Johnson et al., 2009;
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Shull, 2011). In the current study, there was a complete reversal of running bout
behaviors compared to the previous use of ovariectomized females (Cranston, 2016),
with an increase in bout number in the intact females similar to that observed in F344/N
controls. Further, the male animals in the current study replicated the results of the
previous study, with a significant reduction in running bouts in HIV-1 animals compared
to F344/N controls. These results suggest that circulating, and potentially even
administered ovarian hormones may be capable of improving motivational differences in
the HIV-1 Tg rat.
Ovarian hormones have multiple positive effects outside of the CNS and
peripheral nervous system. In the periphery, both estrogen receptors, estrogen receptor
alpha (ERα) & estrogen receptor Beta (ERβ) have been shown to both promote and
inhibit gene expression (Gustafsson, Zhao, Gustafsson, & Dahlman-Wright, 2010;
Lindberg et al., 2003; Zhao, Dahlman-Wright, & Gustafsson, 2010). In the cardiovascular
system, ovarian hormones (specifically estrogen) has been shown to control cardiac
relaxation (Knowlton & Korzick, 2014; Knowlton & Lee, 2012; Schulz, 2005), therefore
it appears estrogen is important for inhibiting vasoconstriction (Arenas, Armstrong, Xu,
& Davidge, 2006; Stice, Eiserich, & Knowlton, 2009; Wynne, Payne, Cain, Reckelhoff,
& Khalil, 2004). Additionally, estrogen appears to help attenuate vascular injury (Patten,
2004; Pelzer et al., 2005; M. Wang, Crisostomo, Wairiuko, & Meldrum, 2006; M. Wang
et al., 2009; Favre et al., 2010) as well as preventing the damage associated with cardiac
ischemic insults (E. A. Booth & Lucchesi, 2008; Deschamps, Murphy, & Sun, 2010).
There is evidence that estrogen also plays a role in the prevention of atherosclerosis and
the female (premenopausal) reduction in cardiovascular disease compared to younger
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males (Knowlton & Lee, 2012; Mendelsohn & Karas, 1999). Related to this, estrogen
appears to reduce monocyte adhesion to venous walls (Simoncini, De Caterina, &
Genazzani, 1999) which promotes the development of atherosclerosis.
Physical activity also has pronounced effects on human physiological function,
including the prevention of many chronic diseases (F. W. Booth, Roberts, & Laye, 2012)
and mortality (Myers et al., 2002). Consistent physical activity has been shown to
improve fatigue and apathy in persons with medical conditions (O’Connor & Puetz,
2005), promote weight loss/weight maintenance by increasing resting metabolic rate and
VO2MAX (Gim & Choi, 2016), prevention of metabolic syndrome and diabetes risk
(Eriksson, Taimela, & Koivisto, 1997; Siscovick, LaPorte, & Newman, 1985), and
increase bone strength (Zulfarina et al., 2016) depending on the type of exercise
performed (Tenforde & Fredericson, 2011). In addition, physical activity has been shown
to reduce inflammation, especially inflammation associated with aging (Woods, Wilund,
Martin, & Kistler, 2012) and acute and chronic inflammation due to disease states
(Woods, Vieira, & Keylock, 2009). The reduction in inflammation may be due to
multiple pro-inflammatory mechanisms including a reduction in inflammatory adipose
tissue (You, Berman, Ryan, & Nicklas, 2004), reduction in macrophage accumulation
due to adipose tissue (Weisberg et al., 2003; H. Xu et al., 2003), increased production of
cytokine IL-6 (which is antinflammatory as an antagonist of TNFα when produced by
muscles) (Keller et al., 2003), and the cholinergic anti-inflammatory pathway, which can
be stimulated by the vagus nerve (Pavlov & Tracey, 2005, 2006).
The current study did not find any evidence that wheel running improved working
memory in the spontaneous alternation Y maze task. However, in the F344/N control
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animals, wheel running did improve accuracy in this particular procedure for the Y maze
task, although this improvement in accuracy did not reach statistical significance. The
current study determined the increased abGC genesis was not associated with cognitive
improvements in the HIV-1 Tg rat, potentially due to the selection of the Y maze task, or
the ITI lengths used in this study. Perhaps this result was due to the selection of the
spontaneous alternation Y maze task, and other cognitive tasks (such as attention, fear
conditioning, spatial memory, or executive function) may show improvement following
wheel running. Furthermore, perhaps the ITI selected (60 seconds) was not sufficient to
identify an improvement in this task, as all animals and all groups performed this
working memory task at greater than 75% accuracy (evidence of a potential ceiling
effect).
However, there are several caveats that must be addressed based on the results of
the current study. First, the implications for the current study on HIV-1 positive humans
must be cautious. There is a very limited evidence of the role of the HIV-1 viral proteins
on neurogenesis in the human hippocampus, primarily due to ethical issues surrounding
the use of human brain tissues which are required to examine neurogenesis in human
HIV-1 patients (Ferrell & Giunta, 2014; Kaul, 2008, 2009; Krathwohl & Kaiser, 2004;
Schwartz et al., 2007). Second, whether wheel running-induced neurogenesis found in
rodent models directly translates to human neurogenesis is still questionable, and there is
some controversy as to whether or not human brains are even capable of adult
neurogenesis (Sorrells et al., 2018). Third, while we have provided evidence that chronic
expression of the HIV-1 viral proteins inhibit neurogenesis in the HIV-1 Tg rat, we have
not examined a mechanism for this inhibition. Notch1 signaling is vital for proliferation

104

of abGCs, and Notch1 signaling is affected by the HIV-1 viral proteins (Breunig et al.,
2007; Fan et al., 2016; Lugert et al., 2010), however the current study did not evaluate the
role of Notch1, or whether physical activity can affect Notch1 signaling. Finally, the
animals in the current study were allowed access to the running wheel for only ~66/day
during their nocturnal phase of their circadian rhythm, because of this, only a small
"snapshot" of their overall daily activity was measured. In future studies, it may be more
advantageous to allow 24h access to the running wheels to better understand the groups
in voluntary wheel running (Bjørnebekk, Mathé, & Brené, 2005).
In conclusion, the current study has provided evidence that there are significant
sex differences in both the HIV-1 Tg rat and F344/N controls, not only in behaviors, but
also neuroanatomically. The current study also provided evidence that neurogenesis in
the HIV-1 Tg rat is inhibited by the chronic expression of the HIV-1 viral proteins in
vivo. Importantly, the current study established that the HIV-1 transgene does not affect
female estrus cycle cyclicity nor length of the estrus stage. Further, in wheel running
behaviors, the female HIV-1 Tg animals increased their wheel running distances when in
the estrus phase of their estrous cycle, similar to the F344/N control female animals.
Additionally, it was shown that wheel running did not have a statistically significant
effect on the creation/survival of abGCs in the current study. However, the current study
also provided evidence that independent of neurogenesis, wheel running in rats is capable
of promoting granule cell dendrite growth, and distal branching complexity. Further,
wheel running significantly increased dendritic spine length, head diameter, and volume
compared to sedentary animals, an effect which was found in both genotypic groups.
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The latter result suggests that wheel running may be able to attenuate the established
synaptodendritic damage associated with the expression of the HIV-1 viral proteins in the
HIV-1 Tg rat. Unfortunately, this recovery did not improve the accuracy of the HIV-1 Tg
animals in the spontaneous alternation Y maze task, as there were no statistically
significant differences due to wheel running, even in F344/N control animals. Finally, the
results of the current study paired with the results of the previous study (Cranston, 2016)
suggest that ovarian hormones (such as estrogens and progestins) may be a potential
therapeutic able to improve motivational alterations (apathy) in the HIV-1 Tg rat
(Bertrand et al., 2018).
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